{
  "meta": {
    "id": "test15",
    "title": "Schizophrenia and Other Primary Psychotic Disorders",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Which of the following statements best describes Emil Kraepelin\u2019s classification of mental disorders?",
      "options": [
        {
          "label": "A",
          "text": "Dementia praecox was characterized by a decline in cognitive function, while manic-depressive psychosis was characterized by fluctuations between depressive and manic episodes.",
          "correct": true
        },
        {
          "label": "B",
          "text": "Dementia praecox referred to a cognitive decline in young individuals, while manic-depressive psychosis was exclusively seen in older adults.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Dementia praecox was an early term for bipolar disorder, while manic-depressive psychosis was an early term for schizophrenia.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Both dementia praecox and manic-depressive psychosis were characterized by psychosis, but dementia praecox was considered a more severe form.",
          "correct": false
        }
      ],
      "correct_answer": "A. Dementia praecox was characterized by a decline in cognitive function, while manic-depressive psychosis was characterized by fluctuations between depressive and manic episodes.",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/24/screenshot-2024-05-24-124930.JPG"
      ],
      "explanation": "<p><strong>Ans. A) Dementia praecox was characterized by a decline in cognitive function, while manic-depressive psychosis was characterized by fluctuations between depressive and manic episodes.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B . This statement is incorrect because Kraepelin did not restrict dementia praecox to young individuals and manic-depressive psychosis to older adults . His classification was based on the type of symptoms and course of the illness rather than the age of onset.</li><li>\u2022 Option</li><li>\u2022 B</li><li>\u2022 incorrect</li><li>\u2022 Kraepelin did not restrict dementia praecox to young individuals and manic-depressive psychosis to older adults</li><li>\u2022 Option C . This statement reverses the modern terms for the disorders Kraepelin described . Dementia praecox is an early term for what is now known as schizophrenia, not bipolar disorder, and manic-depressive psychosis is an early term for what is now known as bipolar disorder, not schizophrenia.</li><li>\u2022 Option</li><li>\u2022 C</li><li>\u2022 reverses the modern terms for the disorders Kraepelin described</li><li>\u2022 Option D. While both conditions involved psychosis, Kraepelin did not characterize dementia praecox simply as a more severe form of psychosis. He distinguished the two based on symptomatology, course, and outcome, with dementia praecox having a more chronic and deteriorating course.</li><li>\u2022 Option</li><li>\u2022 D.</li><li>\u2022 Kraepelin did not characterize dementia praecox simply as a more severe form of psychosis.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Comprehensive Textbook of Psychiatry, 10th edition, Page 1406.</li><li>\u27a4 Ref</li><li>\u27a4 : Kaplan & Sadock\u2019s Comprehensive Textbook of Psychiatry, 10th edition, Page 1406.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5330d860",
      "audio": ""
    },
    {
      "text": "A medical student is studying Bleuler's fundamental symptoms of schizophrenia. According to Bleuler, which of the following is NOT one of the four fundamental symptoms of schizophrenia?",
      "options": [
        {
          "label": "A",
          "text": "Affective disturbances",
          "correct": false
        },
        {
          "label": "B",
          "text": "Association disturbances",
          "correct": false
        },
        {
          "label": "C",
          "text": "Avolition",
          "correct": true
        },
        {
          "label": "D",
          "text": "Autism",
          "correct": false
        }
      ],
      "correct_answer": "C. Avolition",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/screenshot-2024-03-12-142637.jpg"
      ],
      "explanation": "<p><strong>Ans. C) Avolition</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Eugene Bleuler gave 4 A\u2019s of Schizophrenia which are fundamental symptoms. They include:</li><li>\u27a4 Ref : A Short Textbook of Psychiatry, 7th edition, Page No 55.</li><li>\u27a4 Ref</li><li>\u27a4 : A Short Textbook of Psychiatry, 7th edition, Page No 55.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f71222c6",
      "audio": ""
    },
    {
      "text": "Which of the following is NOT considered one of Schneider's first-rank symptoms in the context of schizophrenia?",
      "options": [
        {
          "label": "A",
          "text": "Auditory hallucinations of two or more voices conversing with each other",
          "correct": false
        },
        {
          "label": "B",
          "text": "Thought withdrawal",
          "correct": false
        },
        {
          "label": "C",
          "text": "Somatic hallucinations",
          "correct": true
        },
        {
          "label": "D",
          "text": "Thought broadcast",
          "correct": false
        }
      ],
      "correct_answer": "C. Somatic hallucinations",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Somatic hallucinations</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 \"Somatic Passivity\" (which is as a First Rank Symptom) and \"Somatic hallucinations\" (which is not a First Rank Symptom).</li><li>\u27a4 Somatic Passivity : The patient experiences bodily sensations but attributes them to an external agency or force controlling them (e.g., \"Someone is making me feel this pain\")</li><li>\u27a4 Somatic Passivity</li><li>\u27a4 Somatic hallucinations : False perceptions of sensations in the body without attributing them to external control (e.g., feeling bugs crawling under the skin)</li><li>\u27a4 Somatic hallucinations</li><li>\u27a4 Ref : A Short Textbook of Psychiatry, 7th edition, Page No 55.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ed0f3ab8",
      "audio": ""
    },
    {
      "text": "A 22-year-old male presents to the outpatient psychiatric clinic with his mother. She reports that over the past six months, her son has become increasingly withdrawn, spending most of his time alone in his room. He often talks to himself, claiming that he is speaking with a character from a TV show who instructs him to perform certain tasks. He has also developed odd beliefs, insisting that he has a special ability to control the weather. His sleep pattern has become irregular, and his personal hygiene has significantly deteriorated. Based on these findings, which of the following symptoms of schizophrenia is NOT present in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Delusions",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hallucinations",
          "correct": false
        },
        {
          "label": "C",
          "text": "Negative symptoms",
          "correct": false
        },
        {
          "label": "D",
          "text": "Catatonic symptoms",
          "correct": true
        }
      ],
      "correct_answer": "D. Catatonic symptoms",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Catatonic symptoms</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Delusions - The patient's belief in his special ability to control the weather is an example of a delusion , specifically a delusion of grandeur.</li><li>\u2022 Option A. Delusions -</li><li>\u2022 patient's belief in his special ability to control the weather is an example of a delusion</li><li>\u2022 Option B. Hallucinations - The patient's experience of hearing a character from a TV show speaking to him is suggestive of an auditory hallucination.</li><li>\u2022 Option B. Hallucinations -</li><li>\u2022 hearing a character from a TV show speaking to him</li><li>\u2022 auditory hallucination.</li><li>\u2022 Option C. Negative symptoms - The patient's social withdrawal (asociality), poor hygiene (avolition), are suggestive of negative symptoms .</li><li>\u2022 Option C. Negative symptoms -</li><li>\u2022 patient's social withdrawal</li><li>\u2022 negative symptoms</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In schizophrenia , positive symptoms include delusions and hallucinations, negative symptoms include social withdrawal and neglect of personal hygiene , and catatonic symptoms involve a marked decrease in reactivity to the environment . Based on the case description, this patient exhibits delusions, hallucinations, and negative symptoms, but there is no evidence of catatonic symptoms.</li><li>\u27a4 schizophrenia</li><li>\u27a4 positive symptoms</li><li>\u27a4 delusions and hallucinations,</li><li>\u27a4 negative symptoms</li><li>\u27a4 social withdrawal and neglect of personal hygiene</li><li>\u27a4 catatonic symptoms</li><li>\u27a4 marked decrease in reactivity to the environment</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 340.</li><li>\u27a4 Ref</li><li>\u27a4 : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 340.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "011c2eeb",
      "audio": ""
    },
    {
      "text": "A 28-year-old female with a history of schizophrenia is brought to the emergency department by her family due to worsening symptoms. On examination, she was found to be completely immobile and unresponsive to external stimuli. Which of the following catatonic symptoms of schizophrenia is most likely present in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Waxy flexibility",
          "correct": false
        },
        {
          "label": "B",
          "text": "Stereotypy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mutism",
          "correct": false
        },
        {
          "label": "D",
          "text": "Stupor",
          "correct": true
        }
      ],
      "correct_answer": "D. Stupor",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/screenshot-2024-03-12-142949.jpg"
      ],
      "explanation": "<p><strong>Ans. D) Stupor</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Waxy flexibility: It refers to the feeling of plastic resistance , which the examiner experiences while making a passive movement on the patient . This feeling is akin to bending a wax candle, hence the name 'waxy flexibility.'</li><li>\u2022 Option A. Waxy flexibility:</li><li>\u2022 feeling of plastic resistance</li><li>\u2022 examiner experiences while making a passive movement on the patient</li><li>\u2022 Option B. Stereotypy: Stereotypy is the spontaneous repetition of odd, purposeless movements .  E.g., A patient would repeatedly and spontaneously do hand-flapping movements.</li><li>\u2022 Option B. Stereotypy:</li><li>\u2022 spontaneous repetition of odd, purposeless movements</li><li>\u2022 Option C. Mutism: Absence of verbal communication or minimal verbal response .</li><li>\u2022 Option C. Mutism:</li><li>\u2022 verbal communication or minimal verbal response</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Clinical features of catatonia include</li><li>\u2022 Ref : Kaplan & Sadock\u2019s Comprehensive Textbook of Psychiatry, 10th edition, Page No 1595.</li><li>\u2022 Ref</li><li>\u2022 : Kaplan & Sadock\u2019s Comprehensive Textbook of Psychiatry, 10th edition, Page No 1595.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ba178931",
      "audio": ""
    },
    {
      "text": "A 24-year-old male patient with a 5-year history of schizophrenia is admitted to the emergency department after a suicide attempt. The patient has a history of auditory hallucinations, delusion of persecution, social withdrawal and had depressed mood, loss of interest, cannabis use and insomnia in the past few weeks. Which of the following factors is most closely associated with an increased risk of suicide in patients with schizophrenia?",
      "options": [
        {
          "label": "A",
          "text": "Comorbid depressive episode",
          "correct": true
        },
        {
          "label": "B",
          "text": "Comorbid substance abuse",
          "correct": false
        },
        {
          "label": "C",
          "text": "Female sex",
          "correct": false
        },
        {
          "label": "D",
          "text": "Poor social support",
          "correct": false
        }
      ],
      "correct_answer": "A. Comorbid depressive episode",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Comorbid depressive episode</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Suicide is the leading cause of premature death in patients with schizophrenia. Around 20-50% of patients with schizophrenia attempt suicide, and approximately 10% of patients with schizophrenia die by suicide. The factor which is most closely associated with suicide risk, would be a comorbid depressive episode.</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 339.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8e7a0951",
      "audio": ""
    },
    {
      "text": "A 30-year-old male with no previous psychiatric history presents to the emergency department with a 6-month history of hearing voices and suspiciousness. He believes that he is being followed by the government and that they are trying to control his mind. He has also become increasingly isolated and withdrawn from his family and friends. On examination, he is found to have disorganized speech, flattened affect, and decreased motivation. Laboratory tests and brain imaging are unremarkable. What is the most likely diagnosis for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Schizophreniform disorder",
          "correct": false
        },
        {
          "label": "B",
          "text": "Schizoaffective disorder",
          "correct": false
        },
        {
          "label": "C",
          "text": "Schizophrenia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Delusional disorder",
          "correct": false
        }
      ],
      "correct_answer": "C. Schizophrenia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Schizophrenia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Schizophreniform disorder is a diagnosis given to patients who present with symptoms of schizophrenia but duration of illness is between one month to six months.</li><li>\u2022 Option A. Schizophreniform disorder</li><li>\u2022 diagnosis given to patients who present with symptoms of schizophrenia but duration of illness</li><li>\u2022 Option B. Schizoaffective disorder is a diagnosis given to patients who have symptoms of both schizophrenia and a mood disorder , such as depression or bipolar disorder . Delusional disorder is a diagnosis given to patients who have persistent delusions without the presence of other schizophrenia symptoms.</li><li>\u2022 Option B. Schizoaffective disorder</li><li>\u2022 given to patients who have symptoms of both schizophrenia and a mood disorder</li><li>\u2022 depression or bipolar disorder</li><li>\u2022 Option D. Delusional disorder is a diagnosis given to patients who have persistent delusions without the presence of other schizophrenia symptoms.</li><li>\u2022 Option D. Delusional disorder</li><li>\u2022 patients who have persistent delusions without the presence of other schizophrenia symptoms.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Schizophrenia is the prototype of psychotic disorder. According to DSM-5, two or more of the following symptoms should be present for the duration of 1 month and at least one of these must be (1), (2), or (3) .</li><li>\u2022 two or more</li><li>\u2022 1 month</li><li>\u2022 at least one of these must be (1), (2), or (3)</li><li>\u2022 Delusions Hallucinations Disorganized speed (or formal thought disorder) Disorganized behavior Negative symptoms</li><li>\u2022 Delusions</li><li>\u2022 Hallucinations</li><li>\u2022 Disorganized speed (or formal thought disorder)</li><li>\u2022 Disorganized behavior</li><li>\u2022 Negative symptoms</li><li>\u2022 Total duration of illness should be at least 6 months and the 6 months period must include at least one month of above-mentioned symptoms.</li><li>\u2022 at least 6 months</li><li>\u2022 The symptoms must also cause significant impairment in social, occupational, or other areas of functioning, and cannot be attributed to the effects of a substance or another medical condition.</li><li>\u2022 significant impairment in social, occupational, or other areas of functioning, and cannot be attributed to the effects</li><li>\u2022 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 341.</li><li>\u2022 Ref</li><li>\u2022 : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 341.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c395cc31",
      "audio": ""
    },
    {
      "text": "A 24-year-old male with a history of schizophrenia was brought by family members due to increased agitation and aggressive behavior. He was administered intramuscular haloperidol, in the emergency department for quick control of symptoms. Within an hour, the patient developed sustained upward deviation of the eyes. What is the next best step in the treatment of this patient?",
      "options": [
        {
          "label": "A",
          "text": "Switch to oral haloperidol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Administer intramuscular olanzapine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Administer intravenous lorazepam",
          "correct": false
        },
        {
          "label": "D",
          "text": "Administer intramuscular promethazine",
          "correct": true
        }
      ],
      "correct_answer": "D. Administer intramuscular promethazine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Administer intramuscular promethazine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Switch to oral haloperidol: It is incorrect because switching to oral haloperidol does not help with the immediate management of dystonia.</li><li>\u2022 Option A. Switch to oral haloperidol:</li><li>\u2022 incorrect</li><li>\u2022 switching to oral haloperidol does not help with the immediate management of dystonia.</li><li>\u2022 Option B. Administer intramuscular olanzapine: It is not appropriate because administering intramuscular olanzapine will not help with dystonia .</li><li>\u2022 Option B. Administer intramuscular olanzapine:</li><li>\u2022 not appropriate</li><li>\u2022 administering intramuscular olanzapine will not help with dystonia</li><li>\u2022 Option C. Administer intravenous lorazepam: This is incorrect because, although lorazepam can help manage agitation, it is not the most appropriate treatment for acute dystonia.</li><li>\u2022 Option C. Administer intravenous lorazepam:</li><li>\u2022 incorrect</li><li>\u2022 lorazepam can help manage agitation, it is not the most appropriate treatment for acute dystonia.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Acute dystonia is the earliest side effect of antipsychotics can be seen within minutes of receiving an injectable antipsychotic (also with oral antipsychotic). It is characterized by sudden contraction of a muscle group and can lead to symptoms like torticollis (twisting of the neck), oculogyric crisis (deviation of eyeballs), opisthotonos (extreme arching of the back), trismus (contraction of jaw muscles) or other dystonic reactions. Treatment of acute dystonia involves immediate administration of parental anticholinergics such as benztropine, promethazine, or diphenhydramine. To prevent acute dystonia, prophylactic use of oral anticholinergics is suggested while prescribing typical antipsychotics.</li><li>\u27a4 Acute dystonia</li><li>\u27a4 earliest side effect</li><li>\u27a4 sudden contraction</li><li>\u27a4 torticollis</li><li>\u27a4 oculogyric crisis</li><li>\u27a4 opisthotonos</li><li>\u27a4 anticholinergics</li><li>\u27a4 Ref : The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 110-111.</li><li>\u27a4 Ref</li><li>\u27a4 : The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 110-111.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0d1ec1d6",
      "audio": ""
    },
    {
      "text": "A 24-year-old male patient presents to the psychiatric clinic with a history of social withdrawal, delusions, and auditory hallucinations. The patient has been diagnosed with schizophrenia and is being started on haloperidol for management. To prevent the development of extrapyramidal symptoms (EPS), which drug should be given prophylactically?",
      "options": [
        {
          "label": "A",
          "text": "Lorazepam",
          "correct": false
        },
        {
          "label": "B",
          "text": "Benztropine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Propranolol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Fluoxetine",
          "correct": false
        }
      ],
      "correct_answer": "B. Benztropine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Benztropine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Lorazepam is a benzodiazepine and not typically used for preventing EPS in patients on antipsychotic medications.</li><li>\u2022 Option A. Lorazepam</li><li>\u2022 benzodiazepine and not typically used for preventing EPS</li><li>\u2022 Option C. Propranolol is a beta-blocker that may help manage akathisia , a specific type of EPS, but it is not typically used as a prophylactic measure to prevent EPS.</li><li>\u2022 Option C. Propranolol</li><li>\u2022 beta-blocker that may help manage akathisia</li><li>\u2022 Option D. Fluoxetine is a selective serotonin reuptake inhibitor (SSRI), it does not have a role in preventing EPS in patients on antipsychotic medications.</li><li>\u2022 Option D. Fluoxetine</li><li>\u2022 selective serotonin reuptake inhibitor</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 To prevent the development of extrapyramidal symptoms associated with first-generation antipsychotic medications like haloperidol, anticholinergic agents such as benztropine are commonly used . Benztropine can help counteract the dopaminergic blockade in the nigrostriatal pathway, which is thought to contribute to the development of EPS.</li><li>\u27a4 prevent the development of extrapyramidal symptoms associated with first-generation antipsychotic medications</li><li>\u27a4 haloperidol, anticholinergic agents such as benztropine are commonly used</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 351.</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 351.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b8629d8d",
      "audio": ""
    },
    {
      "text": "A 24-year-old male with a history of schizophrenia was recently started on haloperidol for treatment of his psychotic symptoms. Three days after starting the medication, he presents to the emergency room with a high fever of 104\u00b0F, diaphoresis, tachycardia, muscle rigidity, and altered mental status. His laboratory results show elevated creatine kinase and leukocytosis. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Serotonin Syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Acute akathisa",
          "correct": false
        },
        {
          "label": "C",
          "text": "Acute Dystonia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Neuroleptic Malignant Syndrome",
          "correct": true
        }
      ],
      "correct_answer": "D. Neuroleptic Malignant Syndrome",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/picture2_DpCtKQs.jpg"
      ],
      "explanation": "<p><strong>Ans. D) Neuroleptic Malignant Syndrome</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Serotonin syndrome typically occurs due to the use of serotonergic medications , such as selective serotonin reuptake inhibitors (SSRIs).</li><li>\u2022 Option A. Serotonin syndrome</li><li>\u2022 due to the use of serotonergic medications</li><li>\u2022 selective serotonin reuptake inhibitors</li><li>\u2022 Option B. Acute Akathisia is an extrapyramidal side effect of antipsychotic medications , characterized by a subjective feeling of inner restlessness and objective signs of restlessness . While it can occur after starting an antipsychotic, the fever, muscle rigidity, and autonomic instability seen in this case are not characteristic of acute akathisia.</li><li>\u2022 Option B. Acute Akathisia</li><li>\u2022 extrapyramidal side effect of antipsychotic medications</li><li>\u2022 subjective feeling of inner restlessness and objective signs of restlessness</li><li>\u2022 Option C. Acute Dystonia is an extrapyramidal side effect of antipsychotic medications, characterized by sudden, involuntary muscle contractions and can present as torticollis, oculogyric crisis, or other focal dystonias . While it can occur after starting an antipsychotic, the fever and autonomic instability seen in this case are not characteristic of acute dystonia.</li><li>\u2022 Option C. Acute Dystonia</li><li>\u2022 extrapyramidal side effect of antipsychotic medications,</li><li>\u2022 sudden, involuntary muscle contractions</li><li>\u2022 present as torticollis, oculogyric crisis, or other focal dystonias</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 NMS is a fatal side effect of antipsychotic use . It is characterized by the following cardinal symptoms:</li><li>\u27a4 NMS is a fatal side effect of antipsychotic use</li><li>\u27a4 Fever, typically greater than 100.4\u00b0F (38\u00b0C) Muscle rigidity Altered mental status: Confusion, agitation, or stupor Autonomic instability: Tachycardia, diaphoresis, labile blood pressure, and tachypnea</li><li>\u27a4 Fever, typically greater than 100.4\u00b0F (38\u00b0C)</li><li>\u27a4 Muscle rigidity</li><li>\u27a4 Altered mental status: Confusion, agitation, or stupor</li><li>\u27a4 Autonomic instability: Tachycardia, diaphoresis, labile blood pressure, and tachypnea</li><li>\u27a4 Laboratory findings include elevated creatine kinase, leukocytosis, elevated liver enzymes and sometimes acute renal failure due to rhabdomyolysis.</li><li>\u27a4 PATHOPHYSIOLOGY OF NMS :</li><li>\u27a4 PATHOPHYSIOLOGY OF NMS</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 594-595.</li><li>\u27a4 Ref</li><li>\u27a4 : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 594-595.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d46aa2f8",
      "audio": ""
    },
    {
      "text": "A 24-year-old male with a history of schizophrenia was recently started on haloperidol for treatment of his psychotic symptoms. Three days after starting the medication, he presents to the emergency room with fever (104\u00b0F), diaphoresis, tachycardia, muscle rigidity, and altered sensorium. What is the most appropriate next investigation?",
      "options": [
        {
          "label": "A",
          "text": "Kidney function tests",
          "correct": false
        },
        {
          "label": "B",
          "text": "Thyroid function tests",
          "correct": false
        },
        {
          "label": "C",
          "text": "Serum creatine kinase level",
          "correct": true
        },
        {
          "label": "D",
          "text": "Liver function tests",
          "correct": false
        }
      ],
      "correct_answer": "C. Serum creatine kinase level",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Serum creatine kinase level</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Kidney function tests: While kidney function tests, such as blood urea nitrogen (BUN) and creatinine , are important in evaluating a patient's overall condition and potential renal complications, they are not specific for diagnosing NMS . However, these tests should be performed in conjunction with CK levels to monitor kidney function.</li><li>\u2022 Option A. Kidney function tests:</li><li>\u2022 blood urea nitrogen</li><li>\u2022 creatinine</li><li>\u2022 not specific for diagnosing NMS</li><li>\u2022 Option B. Thyroid function tests: Although thyroid dysfunction can present with altered mental status and autonomic instability , the presence of fever and muscle rigidity in this case strongly suggests NMS . Thyroid function tests may be considered in the differential diagnosis, but they are not the priority investigation in this specific clinical scenario.</li><li>\u2022 Option B. Thyroid function tests:</li><li>\u2022 present with altered mental status and autonomic instability</li><li>\u2022 presence of fever and muscle rigidity in this case strongly suggests NMS</li><li>\u2022 not the priority investigation</li><li>\u2022 Option D. Liver function tests: Liver function tests can be deranged in NMS , but they are not specific for diagnosing NMS . They may be considered as part of a broader assessment, but CK levels should be prioritized in this case.</li><li>\u2022 Option D. Liver function tests:</li><li>\u2022 deranged in NMS</li><li>\u2022 not specific for diagnosing NMS</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In the context of a patient presenting with symptoms suggestive of Neuroleptic Malignant Syndrome (NMS) after starting an antipsychotic medication , the most appropriate initial investigation is the serum creatine kinase level . Elevated CK levels are indicative of muscle breakdown and are a key diagnostic feature of NMS.</li><li>\u27a4 symptoms suggestive of Neuroleptic Malignant Syndrome</li><li>\u27a4 starting an antipsychotic medication</li><li>\u27a4 initial investigation is the serum creatine kinase level</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 594-595.</li><li>\u27a4 Ref</li><li>\u27a4 : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 594-595.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c140abdc",
      "audio": ""
    },
    {
      "text": "A 35-year-old female with a history of bipolar disorder was recently started on olanzapine for the management of her manic symptoms. Five days after starting the medication, she presents to the emergency room with high-grade fever, diaphoresis, tachycardia, muscle rigidity, and confusion. Her laboratory results show elevated creatine kinase and leukocytosis. The clinical presentation is consistent with Neuroleptic Malignant Syndrome (NMS). What is the drug of choice for the treatment of NMS?",
      "options": [
        {
          "label": "A",
          "text": "Bromocriptine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Benztropine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Dantrolene",
          "correct": true
        },
        {
          "label": "D",
          "text": "Lorazepam",
          "correct": false
        }
      ],
      "correct_answer": "C. Dantrolene",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Dantrolene</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Bromocriptine: In some cases, dopamine agonists like bromocriptine may also be used to alleviate symptoms .</li><li>\u2022 Option A. Bromocriptine:</li><li>\u2022 dopamine agonists like bromocriptine may also be used to alleviate symptoms</li><li>\u2022 Option B Benztropine: It is an anticholinergic agent used primarily to treat extrapyramidal side effects (EPS).</li><li>\u2022 Option B Benztropine:</li><li>\u2022 anticholinergic agent used primarily to treat extrapyramidal side effects</li><li>\u2022 Option D. Lorazepam: It can be used as an adjunct treatment for NMS to help manage agitation and provide sedation , but it is not the primary treatment for NMS, as it does not address the core features of the syndrome.</li><li>\u2022 Option D. Lorazepam:</li><li>\u2022 adjunct treatment for NMS to help manage agitation and provide sedation</li><li>\u2022 Kindy note neuroleptic malignant syndrome is rare with second-generation antipsychotics like olanzapine.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Treatment includes discontinuing the antipsychotic medication, providing supportive care, and considering the use of a medication like dantrolene , dopamine agonists such as amantadine and bromocriptine to address the dopamine dysregulation associated with NMS.</li><li>\u2022 Treatment includes discontinuing the antipsychotic medication, providing supportive care, and considering the use of a medication</li><li>\u2022 dantrolene</li><li>\u2022 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 594-595.</li><li>\u2022 Ref</li><li>\u2022 : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 594-595.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9dbfcc27",
      "audio": ""
    },
    {
      "text": "A 28-year-old obese female patient with schizophrenia is currently being treated with risperidone. She has recently developed galactorrhea. What should be the next step in her treatment?",
      "options": [
        {
          "label": "A",
          "text": "Switch to olanzapine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Switch to haloperidol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Switch to amisulpride",
          "correct": false
        },
        {
          "label": "D",
          "text": "Switch to aripiprazole",
          "correct": true
        }
      ],
      "correct_answer": "D. Switch to aripiprazole",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Switch to aripiprazole</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Switch to olanzapine: While olanzapine is a second-generation antipsychotic with a lower risk of hyperprolactinemia compared to risperidone , it is associated with a higher risk of weight gain and metabolic side effects . Given the patient's obesity, olanzapine may not be the best choice.</li><li>\u2022 Option A. Switch to olanzapine:</li><li>\u2022 second-generation antipsychotic with a lower risk of hyperprolactinemia compared to risperidone</li><li>\u2022 higher risk of weight gain and metabolic side effects</li><li>\u2022 Option B. Switch to haloperidol: Haloperidol is a first-generation antipsychotic that can also cause hyperprolactinemia , and it has a higher risk of extrapyramidal side effects compared to second-generation antipsychotics . Switching to haloperidol may not alleviate the patient's galactorrhea and could introduce additional side effects.</li><li>\u2022 Option B. Switch to haloperidol:</li><li>\u2022 first-generation antipsychotic that can also cause hyperprolactinemia</li><li>\u2022 higher risk of extrapyramidal side effects compared to second-generation antipsychotics</li><li>\u2022 Option C. Switch to amisulpride: Amisulpride is another second-generation antipsychotic that can cause hyperprolactinemia. Switching to amisulpride may not effectively address the patient's galactorrhea and could potentially exacerbate the issue.</li><li>\u2022 Option C. Switch to amisulpride:</li><li>\u2022 second-generation antipsychotic that can cause hyperprolactinemia.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hyperprolactinemia can occur secondary to antipsychotic use due to blockage of D2 receptors in the tuberoinfundibular tract . Clinical features include galactorrhea, menstrual disturbances in females and gynecomastia, impotence in males. Drug of choice is aripiprazole .</li><li>\u27a4 tuberoinfundibular tract</li><li>\u27a4 Drug of choice</li><li>\u27a4 aripiprazole</li><li>\u27a4 Ref : The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 168-169.</li><li>\u27a4 Ref : The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 168-169.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4ea60a1f",
      "audio": ""
    },
    {
      "text": "All of the following factors are associated with a good prognosis in schizophrenia, except:",
      "options": [
        {
          "label": "A",
          "text": "Late age of onset",
          "correct": false
        },
        {
          "label": "B",
          "text": "Acute onset",
          "correct": false
        },
        {
          "label": "C",
          "text": "Presence of mood symptoms",
          "correct": false
        },
        {
          "label": "D",
          "text": "Predominance of negative symptoms",
          "correct": true
        }
      ],
      "correct_answer": "D. Predominance of negative symptoms",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/screenshot-2024-03-12-143233.jpg"
      ],
      "explanation": "<p><strong>Ans. D) Predominance of negative symptoms</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Late age of onset: Typically, a later age of onset is associated with a better prognosis in schizophrenia. Early-onset schizophrenia tends to have a more severe course and poorer outcome.</li><li>\u2022 Option A. Late age of onset:</li><li>\u2022 later age of onset is associated with a better prognosis in schizophrenia.</li><li>\u2022 Option B. Acute onset: An acute onset of schizophrenia symptoms, often triggered by a stressful event, tends to be associated with a better prognosis compared to a gradual, insidious onset.</li><li>\u2022 Option B. Acute onset:</li><li>\u2022 often triggered by a stressful event, tends to be associated with a better prognosis</li><li>\u2022 Option C. Presence of mood symptoms: The presence of mood symptoms (depressive or manic symptoms) in the context of schizophrenia can sometimes be associated with a better prognosis , partly because mood symptoms may respond better to treatment compared to core schizophrenic symptoms.</li><li>\u2022 Option C. Presence of mood symptoms:</li><li>\u2022 in the context of schizophrenia can sometimes be associated with a better prognosis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The prognosis in schizophrenia is generally worse with a predominance of negative symptoms . Factors associated with a better prognosis include a later age of onset, acute onset of symptoms, and the presence of mood symptoms.</li><li>\u27a4 prognosis in schizophrenia is generally worse with a predominance of negative symptoms</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 350.</li><li>\u27a4 Ref</li><li>\u27a4 : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 350.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b2198080",
      "audio": ""
    },
    {
      "text": "A 30-year-old woman presents to the psychiatric clinic with a 2-year history of mood episodes, including periods of elevated mood, grandiose ideas, increased energy levels, and decreased need for sleep, as well as episodes of depressed mood, lack of interest, insomnia and anhedonia. She has also experienced persistent auditory hallucinations and delusion of persecution during these mood episodes, and these symptoms have been present even during periods of euthymic mood. Currently, the patient reports experiencing a depressed mood, anhedonia, and persistent auditory hallucinations. Which of the following diagnoses is most appropriate for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Bipolar I Disorder, Current Episode Depressive with Psychotic Symptoms",
          "correct": false
        },
        {
          "label": "B",
          "text": "Bipolar I Disorder, Current Episode Manic with Psychotic Symptoms",
          "correct": false
        },
        {
          "label": "C",
          "text": "Schizophrenia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Schizoaffective Disorder",
          "correct": true
        }
      ],
      "correct_answer": "D. Schizoaffective Disorder",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Schizoaffective Disorder</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Bipolar I Disorder, Current Episode Depressive with Psychotic Symptoms: While the patient does have episodes of depression with psychotic symptoms , this diagnosis does not account for the psychotic symptoms occurring outside of the mood episodes.</li><li>\u2022 Option A. Bipolar I Disorder, Current Episode Depressive with Psychotic Symptoms:</li><li>\u2022 patient does have episodes of depression with psychotic symptoms</li><li>\u2022 not account for the psychotic symptoms</li><li>\u2022 Option B. Bipolar I Disorder, Current Episode Manic with Psychotic Symptoms: The patient is currently experiencing a depressive episode, not a manic episode , and the presence of psychotic symptoms outside of mood episodes is not accounted for by this diagnosis.</li><li>\u2022 Option B. Bipolar I Disorder, Current Episode Manic with Psychotic Symptoms:</li><li>\u2022 experiencing a depressive episode, not a manic episode</li><li>\u2022 Option C. Schizophrenia: While the patient has psychotic symptoms, the presence of significant mood episodes (both manic and depressive) that are a prominent part of the clinical picture suggests a diagnosis that incorporates both mood and psychotic features, which is more consistent with Schizoaffective Disorder.</li><li>\u2022 Option C. Schizophrenia:</li><li>\u2022 patient has psychotic symptoms, the presence of significant mood episodes</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Schizoaffective disorder is characterized by the presence of symptoms of both schizophrenia and mood disorder . Management of schizoaffective disorder include:</li><li>\u27a4 Schizoaffective disorder</li><li>\u27a4 presence of symptoms of both schizophrenia and mood disorder</li><li>\u27a4 Schizoaffective disorder (bipolar type or manic type)-  Use a combination of antipsychotics and mood stabilisers Schizoaffective disorder (depressive type)-  Use a combination of antipsychotics and antidepressants</li><li>\u27a4 Schizoaffective disorder (bipolar type or manic type)-  Use a combination of antipsychotics and mood stabilisers</li><li>\u27a4 Schizoaffective disorder (bipolar type or manic type)-  Use a combination of antipsychotics and mood stabilisers</li><li>\u27a4 Schizoaffective disorder (depressive type)-  Use a combination of antipsychotics and antidepressants</li><li>\u27a4 Schizoaffective disorder (depressive type)-  Use a combination of antipsychotics and antidepressants</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 342.</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 342.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "33dd8431",
      "audio": ""
    },
    {
      "text": "Among various psychiatric conditions, one specific disorder has a notable difference in classification between the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) and the International Classification of Diseases, 11th Revision (ICD-11). Which of the following disorders is considered a personality disorder in the DSM-5 and a part of the schizophrenia or other primary psychotic disorders group in the ICD-11?",
      "options": [
        {
          "label": "A",
          "text": "Schizotypal Personality Disorder",
          "correct": true
        },
        {
          "label": "B",
          "text": "Borderline Personality Disorder",
          "correct": false
        },
        {
          "label": "C",
          "text": "Narcissistic Personality Disorder",
          "correct": false
        },
        {
          "label": "D",
          "text": "Antisocial Personality Disorder",
          "correct": false
        }
      ],
      "correct_answer": "A. Schizotypal Personality Disorder",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Schizotypal Personality Disorder</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Borderline Personality Disorder , Option C. Narcissistic Personality Disorder , and Option D. Antisocial Personality Disorde r are consistently classified as personality disorders across both the DSM-5 and the ICD-11 .</li><li>\u2022 Option B. Borderline Personality Disorder</li><li>\u2022 Option C. Narcissistic Personality Disorder</li><li>\u2022 Option D. Antisocial Personality Disorde</li><li>\u2022 personality disorders across both the DSM-5 and the ICD-11</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Schizotypal Personality Disorder is categorized as a personality disorder in the DSM-5 but is considered part of the schizophrenia or other primary psychotic disorders group in the ICD-11 , highlighting a notable difference in classification between these two diagnostic systems.</li><li>\u27a4 Schizotypal Personality Disorder</li><li>\u27a4 personality disorder in the DSM-5</li><li>\u27a4 considered part of the schizophrenia or other primary psychotic disorders group in the ICD-11</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 563.</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 563.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "426d7802",
      "audio": ""
    },
    {
      "text": "A 26-year-old female patient with schizophrenia came for a follow-up visit along with her concerned sister. The sister reports that over the past year, there is no hallucinatory behaviour or suspiciousness however, the patient has no interest in social activities, is less verbally expressive, and spends most of her time alone in her room. She has also noticed that her sister has had difficulty maintaining employment due to a lack of motivation and poor self-care. Based on these findings, which of the following negative symptoms of schizophrenia is NOT present in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Avolition",
          "correct": false
        },
        {
          "label": "B",
          "text": "Alogia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anhedonia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Affective flattening",
          "correct": true
        }
      ],
      "correct_answer": "D. Affective flattening",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Affective flattening</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Negative symptoms represent \u201closs of normal functions\u201d of the brain in patients with schizophrenia. Negative symptoms do not respond as well to the antipsychotics as positive symptoms.</li><li>\u27a4 Avolition : Avolition refers to the diminished motivation or drive to engage in goal-directed activities, such as personal grooming, educational pursuits, or work-related tasks.</li><li>\u27a4 Avolition</li><li>\u27a4 Apathy : Apathy is characterized by a lack of concern for the outcome of an action or event, like a student with schizophrenia who fails an exam but appears completely unfazed by the result.</li><li>\u27a4 Apathy</li><li>\u27a4 Anhedonia : Anhedonia is the inability to derive pleasure from activities or relationships that were once enjoyable, such as a cricket fan who ceases to play or watch the sport because he no longer finds it pleasurable.</li><li>\u27a4 Anhedonia</li><li>\u27a4 Asociality : Asociality is a marked disinterest in socializing and a general indifference to social connections, even with close family and friends.</li><li>\u27a4 Asociality</li><li>\u27a4 Affective flattening (or blunting) : Affective flattening describes the limited or severely restricted expression of emotions.</li><li>\u27a4 Affective flattening (or blunting)</li><li>\u27a4 Alogia : Alogia is characterized by reduced speech output.</li><li>\u27a4 Alogia</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 340.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ba4bcb11",
      "audio": ""
    },
    {
      "text": "The dopamine hypothesis of schizophrenia postulates that:",
      "options": [
        {
          "label": "A",
          "text": "Increased dopamine levels in the prefrontal cortex lead to positive symptoms of schizophrenia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Decreased dopamine levels in the prefrontal cortex lead to positive symptoms of schizophrenia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increased dopamine levels in the mesolimbic pathway lead to negative symptoms of schizophrenia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Increased dopamine levels in the mesolimbic pathway lead to positive symptoms of schizophrenia",
          "correct": true
        }
      ],
      "correct_answer": "D. Increased dopamine levels in the mesolimbic pathway lead to positive symptoms of schizophrenia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Increased dopamine levels in the mesolimbic pathway lead to positive symptoms of schizophrenia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Increased dopamine levels in the prefrontal cortex are not directly associated with the positive symptoms of schizophrenia . In fact, the dopamine hypothesis suggests that negative symptoms and cognitive deficits in schizophrenia might be related to decreased dopamine activity in the prefrontal cortex (hypofrontality).</li><li>\u2022 Option</li><li>\u2022 A. Increased dopamine levels in the prefrontal cortex are not directly associated with the positive symptoms of schizophrenia</li><li>\u2022 negative symptoms and cognitive deficits in schizophrenia</li><li>\u2022 decreased dopamine activity in the prefrontal cortex</li><li>\u2022 Option B. Decreased dopamine levels in the prefrontal cortex are thought to contribute to the negative symptoms of schizophrenia (such as apathy, anhedonia, and impaired executive function), not the positive symptoms.</li><li>\u2022 Option</li><li>\u2022 B. Decreased dopamine levels in the prefrontal cortex are thought to contribute to the negative symptoms of schizophrenia</li><li>\u2022 not the positive symptoms.</li><li>\u2022 Option C. Increased dopamine levels in the mesolimbic pathway are associated with positive symptoms of schizophrenia, not negative symptoms . Negative symptoms are more closely related to decreased dopamine activity in the prefrontal cortex.</li><li>\u2022 Option</li><li>\u2022 C. Increased dopamine levels in the mesolimbic pathway are associated with positive symptoms of schizophrenia,</li><li>\u2022 negative symptoms</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The dopamine hypothesis of schizophrenia suggests that an imbalance of dopaminergic activity in the brain contributes to the development of schizophrenia. The hypothesis posits that</li><li>\u27a4 dopamine hypothesis of schizophrenia</li><li>\u27a4 imbalance of dopaminergic activity in the brain contributes to the development of schizophrenia.</li><li>\u27a4 Increased dopaminergic activity in the mesolimbic pathway (which connects the ventral tegmental area to the nucleus accumbens) is responsible for the positive symptoms of schizophrenia. Decreased dopaminergic activity in the mesocortical tract (which connects the ventral tegmental area to the prefrontal cortex) is responsible for the negative symptoms.</li><li>\u27a4 Increased dopaminergic activity in the mesolimbic pathway (which connects the ventral tegmental area to the nucleus accumbens) is responsible for the positive symptoms of schizophrenia.</li><li>\u27a4 Increased dopaminergic activity in the mesolimbic pathway</li><li>\u27a4 Decreased dopaminergic activity in the mesocortical tract (which connects the ventral tegmental area to the prefrontal cortex) is responsible for the negative symptoms.</li><li>\u27a4 Decreased dopaminergic activity in the mesocortical tract</li><li>\u27a4 In addition, some studies have found increased levels of serotonin, increased levels of glutamate and decreased GABA in patients with schizophrenia.</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 361.</li><li>\u27a4 Ref</li><li>\u27a4 : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 361.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "71329655",
      "audio": ""
    },
    {
      "text": "Kretschmer's body type theory suggests a correlation between certain body types and the predisposition to develop schizophrenia. Which body type, according to Kretschmer, is most associated with schizophrenia?",
      "options": [
        {
          "label": "A",
          "text": "Asthenic",
          "correct": true
        },
        {
          "label": "B",
          "text": "Athletic",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pyknic",
          "correct": false
        },
        {
          "label": "D",
          "text": "Dysplastic",
          "correct": false
        }
      ],
      "correct_answer": "A. Asthenic",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Asthenic</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option B. Athletic: The athletic body type is characterized by being muscular and well-proportioned .</li><li>\u2022 Option B. Athletic:</li><li>\u2022 being muscular and well-proportioned</li><li>\u2022 Option C. Pyknic: The pyknic body type is characterized by a short, stocky build with a round body shape . Kretschmer proposed that individuals with this body type were more susceptible to developing bipolar disorders.</li><li>\u2022 Option C. Pyknic:</li><li>\u2022 short, stocky build with a round body shape</li><li>\u2022 Option D. Dysplastic: Dysplastic body types are those that deviate from the typical body proportions, often due to genetic or environmental factors . Kretschmer did not specifically associate this body type with schizophrenia or other mental disorders.</li><li>\u2022 Option D. Dysplastic:</li><li>\u2022 deviate from the typical body proportions, often due to genetic or environmental factors</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Kretschmer's body type theory suggests that the asthenic body type is most associated with schizophrenia . However, it is essential to note that more recent research has not strongly supported these associations, and the role of body type in the development of mental disorders remains inconclusive.</li><li>\u2022 Kretschmer's body type theory</li><li>\u2022 asthenic body type is most associated with schizophrenia</li><li>\u2022 Ref : A Short Textbook of Psychiatry, 7th edition, Page 393.</li><li>\u2022 Ref</li><li>\u2022 : A Short Textbook of Psychiatry, 7th edition, Page 393.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "94db20e3",
      "audio": ""
    },
    {
      "text": "Which of the following is NOT a primary delusion?",
      "options": [
        {
          "label": "A",
          "text": "Delusional mood",
          "correct": false
        },
        {
          "label": "B",
          "text": "Sudden delusional idea",
          "correct": false
        },
        {
          "label": "C",
          "text": "Delusional perception",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nihilistic delusion",
          "correct": true
        }
      ],
      "correct_answer": "D. Nihilistic delusion",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Nihilistic delusion</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Primary delusions arise as a direct result of a morbid psychological process caused by the underlying disorder . They are intrinsic to psychotic conditions, particularly schizophrenia, and include:</li><li>\u2022 Primary delusions arise as a direct result of a morbid psychological process caused by the underlying disorder</li><li>\u2022 Option A. Delusional mood: In delusional mood, the patient experiences that there is something going on that concerns him but is not sure what it is.</li><li>\u2022 Option A. Delusional mood:</li><li>\u2022 patient experiences that there is something going on that concerns him</li><li>\u2022 Option B. Sudden delusional idea: Here, a delusion appears fully formed in the mind of the patient . It is also called \"autochthonous delusion\".</li><li>\u2022 Option B. Sudden delusional idea:</li><li>\u2022 delusion appears fully formed in the mind of the patient</li><li>\u2022 \"autochthonous delusion\".</li><li>\u2022 Option C. Delusional perception: Here, a delusional meaning is attached to a normal perception , in an understandable manner.</li><li>\u2022 Option C. Delusional perception:</li><li>\u2022 delusional meaning is attached to a normal perception</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Primary delusions are those that arise spontaneously and are not derived from previous experiences or external events . Delusional mood, delusional perception, and sudden delusional ideas are examples of primary delusions . Secondary delusions develop secondarily to some other psychopathology. For example, a patient who had auditory hallucinations and heard a voice that repeatedly said, \u201cyou will be killed\u201d, started believing that \u201csomebody wants to kill him\". This \u201cdelusion of persecution\u201d that developed is a secondary delusion as it developed secondarily to the auditory hallucinations.</li><li>\u27a4 Primary delusions</li><li>\u27a4 arise spontaneously and are not derived from previous experiences or external events</li><li>\u27a4 Delusional mood, delusional perception, and sudden delusional ideas are examples of primary delusions</li><li>\u27a4 Secondary delusions</li><li>\u27a4 secondarily to some other psychopathology.</li><li>\u27a4 Ref : Fish\u2019s Clinical Psychopathology, 5th edition, Page 48-49.</li><li>\u27a4 Ref</li><li>\u27a4 : Fish\u2019s Clinical Psychopathology, 5th edition, Page 48-49.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7cb3d300",
      "audio": ""
    },
    {
      "text": "All the statements are correct about schizophrenia, except:",
      "options": [
        {
          "label": "A",
          "text": "It is equally prevalent in males and females",
          "correct": false
        },
        {
          "label": "B",
          "text": "The onset of schizophrenia is at a younger age in females than males",
          "correct": true
        },
        {
          "label": "C",
          "text": "Onset after 45 yrs of age is called \"Late-onset schizophrenia\"",
          "correct": false
        },
        {
          "label": "D",
          "text": "Schizophrenia is more prevalent in lower socioeconomic class",
          "correct": false
        }
      ],
      "correct_answer": "B. The onset of schizophrenia is at a younger age in females than males",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) The onset of schizophrenia is at a younger age in females than males</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. It is equally prevalent in males and females: This statement is correct . Schizophrenia affects males and females with roughly equal prevalence, although the age of onset and symptom presentation can differ between genders.</li><li>\u2022 Option A. It is equally prevalent in males and females:</li><li>\u2022 correct</li><li>\u2022 Option C. Onset after 45 years of age is called \"Late-onset schizophrenia\": This statement is correct . Schizophrenia that begins after the age of 45 is referred to as late-onset schizophrenia.</li><li>\u2022 Option C. Onset after 45 years of age is called \"Late-onset schizophrenia\":</li><li>\u2022 correct</li><li>\u2022 Option D. Schizophrenia is more prevalent in lower socioeconomic class: This statement is correct . Schizophrenia has been found to be more prevalent in lower socioeconomic groups, a phenomenon that is partially explained by the social drift (downward drift) hypothesis , which suggests that individuals with schizophrenia may move to lower socioeconomic status due to the impairments caused by the illness , which include difficulties in finding meaningful employment and become estranged from their families. Therefore, belonging to lower socioeconomic classes does not increase the likelihood of developing schizophrenia; rather, developing schizophrenia can lead to a downward drift in socioeconomic status.</li><li>\u2022 Option D. Schizophrenia is more prevalent in lower socioeconomic class:</li><li>\u2022 correct</li><li>\u2022 lower socioeconomic groups, a phenomenon that is partially explained by the social drift (downward drift) hypothesis ,</li><li>\u2022 individuals with schizophrenia may move to lower socioeconomic status due to the impairments caused by the illness</li><li>\u2022 Few important points on the epidemiology of schizophrenia-</li><li>\u2022 Downward drift hypothesis- According to the downward drift hypothesis , people with schizophrenia are more likely to be found in lower socioeconomic classes (Statement D) because they may experience difficulties in finding meaningful employment and become estranged from their families, causing them to drift down the socioeconomic ladder.</li><li>\u2022 Downward drift hypothesis-</li><li>\u2022 downward drift hypothesis</li><li>\u2022 schizophrenia are more likely to be found in lower socioeconomic classes</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Worldwide lifetime prevalence of Schizophrenia is approximately 0.7 per cent .  Both men and women are equally affected , but the onset of the illness tends to be earlier in males and later in females. The peak age of onset for schizophrenia is in adolescence and young adulthood, typically between 15 and 24 years. However, there is also a second peak in middle age for females. If the onset occurs after the age of 45, it is referred to as \"late-onset schizophrenia. \" It is more common in lower socioeconomic classes.</li><li>\u27a4 Worldwide lifetime prevalence of Schizophrenia is approximately 0.7 per cent</li><li>\u27a4 men and women are equally affected</li><li>\u27a4 \" It is more common in lower socioeconomic classes.</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 357.</li><li>\u27a4 Ref</li><li>\u27a4 : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 357.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9a3cfc2b",
      "audio": ""
    },
    {
      "text": "All the statements are correct about schizophrenia, except:",
      "options": [
        {
          "label": "A",
          "text": "Patients with schizophrenia are more likely to be born in late winter and spring.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cannabis use can increase the risk of schizophrenia by as much as 40%.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Advanced paternal age and urban upbringing are associated with an increased risk of schizophrenia.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Migrants have an increased risk of developing schizophrenia, and the risk is higher for first-generation migrants than the second-generation migrants.",
          "correct": true
        }
      ],
      "correct_answer": "D. Migrants have an increased risk of developing schizophrenia, and the risk is higher for first-generation migrants than the second-generation migrants.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Migrants have an increased risk of developing schizophrenia, and the risk is higher for first-generation migrants than the second generation migrants.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Patients with schizophrenia are more likely to be born in late winter and spring: This is correct . Schizophrenia patients are more likely born in late winter and spring, possibly due to respiratory infections like influenza occurring in autumn/winter increasing the risk. Maternal exposure to influenza during the second trimester is a suggested risk factor, and so is the maternal infection with rubella, but the evidence remains inconclusive.</li><li>\u2022 Option A. Patients with schizophrenia are more likely to be born in late winter and spring:</li><li>\u2022 correct</li><li>\u2022 Option B. Cannabis use can increase the risk of schizophrenia by as much as 40%: This statement is correct . Cannabis use, especially heavy use and use from an early age, is associated with an increased risk of developing psychotic disorders including schizophrenia.</li><li>\u2022 Option B. Cannabis use can increase the risk of schizophrenia by as much as 40%:</li><li>\u2022 correct</li><li>\u2022 Option C. Advanced paternal age and upbringing in urban areas are associated with an increased risk of schizophrenia: This statement is correct . Advanced paternal age has been linked to an increased risk of several neurodevelopmental disorders, including schizophrenia. Similarly, being raised in an urban environment is associated with a higher risk of developing schizophrenia, likely due to factors such as increased stress, pollution, and higher population density.</li><li>\u2022 Option C. Advanced paternal age and upbringing in urban areas are associated with an increased risk of schizophrenia:</li><li>\u2022 correct</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Environmental factors associated with schizophrenia:</li><li>\u2022 Pre and perinatal complications. More likely Birth in late winter and spring. More likely. Hypothesis of maternal exposure to influenza and rubella. Childhood risk factors - More likely to have poorer motor development, speech difficulties, delayed milestones and lower premorbid IQ. Immigrants (second-generation>first-generation) are at higher risk Urban birth and upbringing Drug abuse, especially cannabis Advanced paternal age</li><li>\u2022 Pre and perinatal complications. More likely</li><li>\u2022 Pre and perinatal complications.</li><li>\u2022 Birth in late winter and spring. More likely. Hypothesis of maternal exposure to influenza and rubella.</li><li>\u2022 Birth in late winter and spring.</li><li>\u2022 Childhood risk factors - More likely to have poorer motor development, speech difficulties, delayed milestones and lower premorbid IQ.</li><li>\u2022 Childhood risk factors</li><li>\u2022 Immigrants (second-generation>first-generation) are at higher risk</li><li>\u2022 Immigrants</li><li>\u2022 Urban birth and upbringing</li><li>\u2022 Urban birth and upbringing</li><li>\u2022 Drug abuse, especially cannabis</li><li>\u2022 Drug abuse, especially cannabis</li><li>\u2022 Advanced paternal age</li><li>\u2022 Advanced paternal age</li><li>\u2022 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 357-358.</li><li>\u2022 Ref</li><li>\u2022 : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 357-358.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9a3cfc2b",
      "audio": ""
    },
    {
      "text": "In twin studies, which of the following statements best describes the concordance rate for schizophrenia in monozygotic and dizygotic twins?",
      "options": [
        {
          "label": "A",
          "text": "Monozygotic twins have a lower concordance rate for schizophrenia than dizygotic twins.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Monozygotic twins have a similar concordance rate for schizophrenia as dizygotic twins.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Monozygotic twins have a higher concordance rate for schizophrenia than dizygotic twins.",
          "correct": true
        },
        {
          "label": "D",
          "text": "There is no significant difference in concordance rates for schizophrenia between monozygotic and dizygotic twins.",
          "correct": false
        }
      ],
      "correct_answer": "C. Monozygotic twins have a higher concordance rate for schizophrenia than dizygotic twins.",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/screenshot-2024-03-12-142816.jpg"
      ],
      "explanation": "<p><strong>Ans. C) Monozygotic twins have a higher concordance rate for schizophrenia than dizygotic twins.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. This statement is incorrect as monozygotic twins have a higher, not lower , concordance rate for schizophrenia compared to dizygotic twins.</li><li>\u2022 Option A.</li><li>\u2022 incorrect</li><li>\u2022 monozygotic twins have a higher, not lower</li><li>\u2022 concordance rate</li><li>\u2022 Option B . This statement is incorrect as there is a significant difference in concordance rates , with monozygotic twins having a higher rate .</li><li>\u2022 Option</li><li>\u2022 B</li><li>\u2022 incorrect</li><li>\u2022 significant difference in concordance rates</li><li>\u2022 monozygotic twins having a higher rate</li><li>\u2022 Option D. This statement is incorrect as studies do show a significant difference in concordance rates, with monozygotic twins having a higher concordance rate for schizophrenia .</li><li>\u2022 Option</li><li>\u2022 D.</li><li>\u2022 incorrect</li><li>\u2022 monozygotic twins having a higher concordance rate for schizophrenia</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 360-361.</li><li>\u27a4 Ref</li><li>\u27a4 : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 360-361.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8e22ea37",
      "audio": ""
    },
    {
      "text": "A 21-year-old male patient presents to the psychiatric clinic with symptoms of auditory hallucinations, the delusion of persecution, agitation and insomnia. During the initial evaluation, the clinician notes that the patient also has a history of recurrent infections, congenital heart defects, and hypocalcemia. The clinician suspects an association between the patient's psychiatric symptoms and an underlying genetic disorder. Which of the following genetic disorders is most likely associated with the patient's presentation?",
      "options": [
        {
          "label": "A",
          "text": "Turner syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Down syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "DiGeorge syndrome",
          "correct": true
        },
        {
          "label": "D",
          "text": "Marfan syndrome",
          "correct": false
        }
      ],
      "correct_answer": "C. DiGeorge syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) DiGeorge syndrome</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Turner syndrome , Option B. Down syndrome and Option D. Marfan syndrome are not specifically associated with an increased risk of schizophrenia .</li><li>\u2022 Option A. Turner syndrome</li><li>\u2022 Option B. Down syndrome</li><li>\u2022 Option D. Marfan syndrome</li><li>\u2022 not specifically associated with an increased risk of schizophrenia</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Numerous genes seem to be linked to the development of schizophrenia , with nine specific genetic regions identified: 1q, 5q, 6p, 6q, 8p, 10p, 13q, 15q, and 22q. Notably, deletions on chromosome 22q11.2, known as 22q11 deletion syndrome or velocardiofacial syndrome (also referred to as DiGeorge syndrome), have been connected to the onset of schizophrenia in approximately 30% of cases.</li><li>\u27a4 Numerous genes seem to be linked to the development of schizophrenia</li><li>\u27a4 nine specific genetic regions identified: 1q, 5q, 6p, 6q, 8p, 10p, 13q, 15q, and 22q.</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 361.</li><li>\u27a4 Ref</li><li>\u27a4 : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 361.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6b4bb3bf",
      "audio": ""
    },
    {
      "text": "A 29-year-old obese male patient with a history of auditory hallucinations, delusions, and social withdrawal for the past year presents to the clinic. He has no prior history of substance abuse or head trauma. He has been previously treated with first-generation antipsychotic medication, but experienced significant extrapyramidal symptoms, including acute dystonia and troublesome tremors, because of which he stopped the treatment. Which of the following treatment options would be most appropriate for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Clozapine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Haloperidol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Olanzapine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Aripiprazole",
          "correct": true
        }
      ],
      "correct_answer": "D. Aripiprazole",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Aripiprazole</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Clozapine is a second-generation antipsychotic that is the drug of choice in treatment-resistant schizophrenia. However, it is not the first choice due to its risk of serious adverse effects.</li><li>\u2022 Option A. Clozapine</li><li>\u2022 second-generation antipsychotic</li><li>\u2022 Option B. Haloperidol is a first-generation antipsychotic that is not appropriate for this patient, as he has already experienced extrapyramidal side effects from a similar medication.</li><li>\u2022 Option B. Haloperidol</li><li>\u2022 first-generation antipsychotic</li><li>\u2022 Option C. Olanzapine is a second-generation antipsychotic that could potentially be used in this case. However, it has a higher risk of metabolic side effects (e.g., weight gain, hyperglycemia) compared to other atypical antipsychotics. Since the patient is already obese, olanzapine should be avoided.</li><li>\u2022 Option C. Olanzapine</li><li>\u2022 second-generation antipsychotic</li><li>\u2022 higher risk of metabolic side effects</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 In patients with schizophrenia who have experienced significant extrapyramidal side effects from first-generation antipsychotics and have concerns about weight gain, aripiprazole is a suitable treatment option due to its lower risk of EPS and relatively favorable metabolic profile .</li><li>\u2022 schizophrenia</li><li>\u2022 extrapyramidal side effects from first-generation antipsychotics</li><li>\u2022 weight gain, aripiprazole is a suitable treatment option due to its lower risk of EPS and relatively favorable metabolic profile</li><li>\u2022 Ref : The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 123.</li><li>\u2022 Ref</li><li>\u2022 : The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 123.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0d5faee0",
      "audio": ""
    },
    {
      "text": "Which of the following statements about the differences between typical and atypical antipsychotics is NOT true?",
      "options": [
        {
          "label": "A",
          "text": "Typical antipsychotics primarily target dopamine D2 receptors, while atypical antipsychotics target both dopamine D2 and serotonin 5-HT2A receptors.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Atypical antipsychotics generally have a lower risk of extrapyramidal side effects compared to typical antipsychotics.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Atypical antipsychotics are more effective in treating negative symptoms of schizophrenia than typical antipsychotics.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Typical antipsychotics have a higher risk of causing metabolic side effects compared to atypical antipsychotics.",
          "correct": true
        }
      ],
      "correct_answer": "D. Typical antipsychotics have a higher risk of causing metabolic side effects compared to atypical antipsychotics.",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/flow-chart-2.jpg"
      ],
      "explanation": "<p><strong>Ans. D) Typical antipsychotics have a higher risk of causing metabolic side effects compared to atypical antipsychotics.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Typical and atypical antipsychotics differ in their mechanism of action , side effect profiles, and effectiveness in treating various symptoms of schizophrenia.</li><li>\u2022 Typical and atypical antipsychotics differ in their mechanism of action</li><li>\u2022 Option A. This statement is true . Typical antipsychotics primarily target dopamine D2 receptors , which helps treat positive symptoms of schizophrenia , such as hallucinations and delusions. Atypical antipsychotics, on the other hand, target both dopamine D2 and serotonin 5-HT2A receptors. This broader mechanism of action allows atypical antipsychotics to address both positive and negative symptoms of schizophrenia.</li><li>\u2022 Option</li><li>\u2022 A.</li><li>\u2022 true</li><li>\u2022 Typical antipsychotics primarily target dopamine D2 receptors</li><li>\u2022 treat positive symptoms of schizophrenia</li><li>\u2022 Option B. This statement is also true . Atypical antipsychotics have a lower risk of causing extrapyramidal side effects (EPS), such as tardive dyskinesia, dystonia, and drug induced parkinsonism, compared to typical antipsychotics. This is one of the main reasons why atypical antipsychotics are generally preferred over typical antipsychotics as the first line treatment of schizophrenia.</li><li>\u2022 Option</li><li>\u2022 B.</li><li>\u2022 true</li><li>\u2022 Atypical antipsychotics</li><li>\u2022 lower risk of causing extrapyramidal side effects</li><li>\u2022 Option C. This statement is true as well . Atypical antipsychotics are more effective in treating negative symptoms of schizophrenia , such as apathy, anhedonia, and affective flattening, compared to typical antipsychotics. The effectiveness of atypical antipsychotics in treating negative symptoms of schizophrenia is believed to be mediated by their action on both dopamine and serotonin receptors. Specifically, the antagonism of serotonin 5-HT2A receptors is thought to play a significant role in improving negative symptoms.</li><li>\u2022 Option</li><li>\u2022 C.</li><li>\u2022 true as well</li><li>\u2022 Atypical antipsychotics</li><li>\u2022 effective in treating negative symptoms of schizophrenia</li><li>\u2022 The exact mechanism is not fully understood, but it is hypothesized that the blockade of 5-HT2A receptors leads to an increase in dopamine release in certain brain regions, such as the prefrontal cortex. This increase in dopamine can help alleviate negative symptoms, as they are often associated with reduced dopaminergic activity in the prefrontal cortex. Remember, decreased dopamine activity in mesocortical pathway is responsible for negative symptoms.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 \u200b\u200bEducational Objective:</li><li>\u27a4 Atypical antipsychotics are associated with a higher risk of metabolic side effects , including weight gain, diabetes, and dyslipidemia , compared to typical antipsychotics . This is contrary to the misconception that typical antipsychotics carry a higher risk of such side effects.</li><li>\u27a4 Atypical antipsychotics</li><li>\u27a4 higher risk of metabolic side effects</li><li>\u27a4 including weight gain, diabetes, and dyslipidemia</li><li>\u27a4 typical antipsychotics</li><li>\u27a4 PATHOPHYSIOLOGY OF ANTIPSYCHOTIC INDUCED WEIGHT GAIN</li><li>\u27a4 PATHOPHYSIOLOGY OF ANTIPSYCHOTIC INDUCED WEIGHT GAIN</li><li>\u27a4 Ref : The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 123.</li><li>\u27a4 Ref</li><li>\u27a4 : The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 123.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "22d93d93",
      "audio": ""
    },
    {
      "text": "A 25-year-old male with a history of schizophrenia was recently started on an antipsychotic medication 2 weeks ago. He is brought to the clinic by his family due to feeling restless, constantly needing to move, and being unable to sit still. He has no other significant medical history. What is the most appropriate treatment for this patient's symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Haloperidol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Propranolol",
          "correct": true
        },
        {
          "label": "C",
          "text": "Sertraline",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tetrabenazine",
          "correct": false
        }
      ],
      "correct_answer": "B. Propranolol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Propranolol</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Haloperidol is a first-generation antipsychotic, which may exacerbate akathisia and is not an appropriate treatment in this case.</li><li>\u2022 Option A. Haloperidol</li><li>\u2022 first-generation antipsychotic,</li><li>\u2022 exacerbate akathisia</li><li>\u2022 Option C. Sertraline is a selective serotonin reuptake inhibitor (SSRI) and is not effective in treating akathisia .</li><li>\u2022 Option C. Sertraline</li><li>\u2022 selective serotonin reuptake inhibitor</li><li>\u2022 not effective in treating akathisia</li><li>\u2022 Option D. Tetrabenazine is a vesicular monoamine transporter 2 (VMAT2) inhibitor , used in the treatment of tardive dyskinesia, not akathisia.</li><li>\u2022 Option D. Tetrabenazine</li><li>\u2022 vesicular monoamine transporter 2</li><li>\u2022 inhibitor</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Acute akathisia is the commonest side effect of antipsychotic medications. It is characterized by an inner sense of restlessness along with objective , observable movements such as fidgeting of legs, pacing around , inability to sit or stand in one place for a long time. Drug of choice is \u03b2-blockers such as propranolol. Other treatment options include anticholinergics and benzodiazepines .</li><li>\u27a4 commonest side effect</li><li>\u27a4 inner sense of restlessness</li><li>\u27a4 objective</li><li>\u27a4 observable movements</li><li>\u27a4 fidgeting</li><li>\u27a4 pacing around</li><li>\u27a4 inability to sit</li><li>\u27a4 stand</li><li>\u27a4 Drug of choice</li><li>\u27a4 \u03b2-blockers</li><li>\u27a4 anticholinergics</li><li>\u27a4 benzodiazepines</li><li>\u27a4 Ref : The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 110-111.</li><li>\u27a4 Ref</li><li>\u27a4 : The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 110-111.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a0cdc515",
      "audio": ""
    },
    {
      "text": "A 32-year-old female with a history of major depressive disorder with psychotic features is prescribed aripiprazole as an adjunct treatment. How does the mechanism of action of aripiprazole differ from other second-generation antipsychotics?",
      "options": [
        {
          "label": "A",
          "text": "Aripiprazole has a higher affinity for serotonin 5-HT2A receptors compared to dopamine D2 receptors",
          "correct": false
        },
        {
          "label": "B",
          "text": "Aripiprazole acts primarily as a dopamine D2 receptor antagonist",
          "correct": false
        },
        {
          "label": "C",
          "text": "Aripiprazole functions as a partial agonist at dopamine D2 receptors and serotonin 5-HT1A receptors",
          "correct": true
        },
        {
          "label": "D",
          "text": "Aripiprazole selectively inhibits serotonin reuptake",
          "correct": false
        }
      ],
      "correct_answer": "C. Aripiprazole functions as a partial agonist at dopamine D2 receptors and serotonin 5-HT1A receptors",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Aripiprazole functions as a partial agonist at dopamine D2 receptors and serotonin 5-HT1A receptors</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. While aripiprazole does interact with serotonin 5-HT2A receptors , its unique characteristic is not a higher affinity for these receptors over dopamine D2 receptors but its partial agonist activity at dopamine D2 and serotonin 5-HT1A receptors.</li><li>\u2022 Option</li><li>\u2022 A.</li><li>\u2022 While aripiprazole does interact with serotonin 5-HT2A receptors</li><li>\u2022 not a higher affinity for these receptors over dopamine D2 receptors</li><li>\u2022 Option B. Aripiprazole is not primarily a dopamine D2 receptor antagonist ; it is a partial agonist at these receptors , which means it can act as both an agonist and an antagonist depending on the level of neurotransmitter activity.</li><li>\u2022 Option</li><li>\u2022 B.</li><li>\u2022 Aripiprazole is not primarily a dopamine D2 receptor antagonist</li><li>\u2022 partial agonist at these receptors</li><li>\u2022 Option D. Aripiprazole does not selectively inhibit serotonin reuptake ; this is a mechanism associated with selective serotonin reuptake inhibitors (SSRIs), a class of antidepressants.</li><li>\u2022 Option</li><li>\u2022 D.</li><li>\u2022 Aripiprazole does not selectively inhibit serotonin reuptake</li><li>\u2022 mechanism associated with selective serotonin reuptake inhibitors</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Aripiprazole's mechanism of action differs from other second-generation antipsychotics in that it functions as a partial agonist at dopamine D2 receptors and serotonin 5-HT1A receptors , and as an antagonist at serotonin 5-HT2A receptors. This allows it to modulate dopamine and serotonin activity in a way that can help stabilize these neurotransmitter systems in conditions like schizophrenia and major depressive disorder with psychotic features. Because of this unique mechanism of action, aripiprazole is associated with a lower risk of extrapyramidal side effects.</li><li>\u27a4 Aripiprazole's mechanism of action differs from other second-generation antipsychotics</li><li>\u27a4 functions as a partial agonist at dopamine D2 receptors and serotonin 5-HT1A receptors</li><li>\u27a4 antagonist at serotonin 5-HT2A receptors.</li><li>\u27a4 Ref : Stahl\u2019s Essential Psychopharmacology, Neuroscientific Basis and Practical Applications, Page 239.</li><li>\u27a4 Ref : Stahl\u2019s Essential Psychopharmacology, Neuroscientific Basis and Practical Applications, Page 239.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d6bbb56a",
      "audio": ""
    },
    {
      "text": "A 26-year-old male presents with symptoms of auditory hallucinations, delusions, and formal thought disorder. He was initially treated with risperidone, but his symptoms did not improve after six weeks of treatment. Subsequently, he was switched to olanzapine, but after another six weeks, his symptoms still persisted. What is the next step in the management of this patient?",
      "options": [
        {
          "label": "A",
          "text": "Add a mood stabilizer to the treatment regimen",
          "correct": false
        },
        {
          "label": "B",
          "text": "Switch to a first-generation antipsychotic",
          "correct": false
        },
        {
          "label": "C",
          "text": "Switch to clozapine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Consider electroconvulsive therapy",
          "correct": false
        }
      ],
      "correct_answer": "C. Switch to clozapine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Switch to clozapine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Adding a mood stabilizer may be helpful in cases of schizoaffective disorder or when there is a comorbid mood disorder.</li><li>\u2022 Option A. Adding a mood stabilizer</li><li>\u2022 helpful in cases of schizoaffective disorder</li><li>\u2022 Option B. Switching to a first-generation antipsychotic can be considered, but it is unlikely to be as effective as clozapine in this case . However, if the patient refuses to consent to clozapine treatment due to the possibility of adverse effects, a switch to a first-generation antipsychotic is a reasonable option.</li><li>\u2022 Option B. Switching to a first-generation antipsychotic</li><li>\u2022 unlikely to be as effective as clozapine in this case</li><li>\u2022 Option D. Electroconvulsive therapy (ECT) can be considered for treatment-resistant schizophrenia when other treatment options, including clozapine, have been ineffective or are not tolerated. However, clozapine should be tried first before considering ECT.</li><li>\u2022 Option D. Electroconvulsive therapy (ECT)</li><li>\u2022 considered for treatment-resistant schizophrenia when other treatment options, including clozapine, have been ineffective</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Treatment-resistant Schizophrenia (TRS) is defined as a lack of response to two different antipsychotics given at adequate dosages for adequate duration of 4 to 6 weeks . Clozapine is the treatment of choice for TRS .</li><li>\u2022 Treatment-resistant Schizophrenia</li><li>\u2022 lack of response to two different antipsychotics</li><li>\u2022 adequate dosages</li><li>\u2022 adequate duration of 4 to 6 weeks</li><li>\u2022 Clozapine</li><li>\u2022 treatment of choice for TRS</li><li>\u2022 Ref : The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 190.</li><li>\u2022 Ref</li><li>\u2022 : The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 190.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9189fa64",
      "audio": ""
    },
    {
      "text": "A 45-year-old male with a history schizophrenia has been responding well to clozapine 100 mg daily. Suddenly, he develops high-grade fever. What is the next step in the management of this patient?",
      "options": [
        {
          "label": "A",
          "text": "Continue clozapine and monitor the patient closely.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Discontinue clozapine immediately and perform a complete blood count (CBC) with differential.",
          "correct": true
        },
        {
          "label": "C",
          "text": "Stop clozapine and order blood tests if the fever doesn't improve within 48 hours.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Switch the patient to a different antipsychotic medication.",
          "correct": false
        }
      ],
      "correct_answer": "B. Discontinue clozapine immediately and perform a complete blood count (CBC) with differential.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Discontinue clozapine immediately and perform a complete blood count (CBC) with differential</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Continuing clozapine and merely monitoring the patient closely without investigating the cause of the fever could put the patient at risk , given the potential for agranulocytosis with clozapine use.</li><li>\u2022 Option A. Continuing clozapine and merely monitoring the patient closely</li><li>\u2022 without investigating</li><li>\u2022 cause of the fever could put the patient at risk</li><li>\u2022 Option C. Waiting 48 hours to order blood tests could delay the diagnosis and management of a potentially life-threatening condition such as agranulocytosis .</li><li>\u2022 Option C. Waiting 48 hours to order blood tests</li><li>\u2022 delay the diagnosis and management of a potentially life-threatening condition</li><li>\u2022 agranulocytosis</li><li>\u2022 Option D. While switching the patient to a different antipsychotic medication may be necessary eventually, the immediate priority is to address the potential cause of the fever, particularly the risk of agranulocytosis. This requires discontinuing clozapine and performing diagnostic tests.</li><li>\u2022 Option D. While switching the patient to a different antipsychotic medication</li><li>\u2022 immediate priority is to address the potential cause of the fever, particularly the risk of agranulocytosis.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The development of high-grade fever in a patient taking clozapine warrants immediate discontinuation of the drug and prompt investigation for agranulocytosis through a complete blood count (CBC) with differential . This is due to clozapine's known risk of causing agranulocytosis, a potentially life-threatening condition.</li><li>\u27a4 development of high-grade fever in a patient taking clozapine warrants immediate discontinuation</li><li>\u27a4 drug and prompt investigation for agranulocytosis</li><li>\u27a4 complete blood count</li><li>\u27a4 with differential</li><li>\u27a4 Schedule for Absolute Neutrophil Count (ANC) monitoring in patients taking clozapine</li><li>\u27a4 Weekly ANC monitoring for the first 6 months Every 2 weeks for the next 6 months (months 7-12) if the ANC remains normal Every 4 weeks after 1 year of continuous therapy if the ANC remains normal</li><li>\u27a4 Weekly ANC monitoring for the first 6 months</li><li>\u27a4 Every 2 weeks for the next 6 months (months 7-12) if the ANC remains normal</li><li>\u27a4 Every 4 weeks after 1 year of continuous therapy if the ANC remains normal</li><li>\u27a4 Ref : The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 222.</li><li>\u27a4 Ref</li><li>\u27a4 : The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 222.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ad4eecc3",
      "audio": ""
    },
    {
      "text": "A 23-year-old male presents to the clinic with a two-week history of fever, followed by the acute onset of psychiatric symptoms, including auditory hallucinations (hearing voices), delusions of persecution, disorganized speech, and emotional lability. Prior to this episode, the patient had no history of psychiatric illness, and there is no evidence of substance abuse. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Schizophrenia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Schizoaffective disorder",
          "correct": false
        },
        {
          "label": "C",
          "text": "Acute and transient psychotic disorder",
          "correct": true
        },
        {
          "label": "D",
          "text": "Delirium",
          "correct": false
        }
      ],
      "correct_answer": "C. Acute and transient psychotic disorder",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Acute and transient psychotic disorder (ATPD)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Schizophrenia: To make a diagnosis of schizophrenia the duration of symptoms should be at least one month according to ICD-11 and at least 6 months according to DSM-5-TR.</li><li>\u2022 Option A. Schizophrenia:</li><li>\u2022 diagnosis of schizophrenia the duration of symptoms should be at least one month</li><li>\u2022 Option B. Schizoaffective disorder: Schizoaffective disorder is characterized by a combination of psychotic and mood symptoms . However, the presentation in this case is more consistent with ATPD due to the sudden onset of symptoms and their short duration.</li><li>\u2022 Option B. Schizoaffective disorder:</li><li>\u2022 characterized by a combination of psychotic and mood symptoms</li><li>\u2022 Option D. Delirium: Although fever can be associated with delirium, the presence of specific psychotic symptoms such as hallucinations and delusions , along with the absence of cognitive impairment or altered level of consciousness , makes ATPD a more likely diagnosis in this case.</li><li>\u2022 Option D. Delirium:</li><li>\u2022 fever can be associated with delirium, the presence of specific psychotic symptoms such as hallucinations and delusions</li><li>\u2022 absence of cognitive impairment or altered level of consciousness</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Acute and Transient Psychotic Disorder is characterized by the sudden onset of intense psychotic symptoms , which are typically short-lived, lasting from a few days to less than a month. This condition is distinguished from schizophrenia and schizoaffective disorder by its acute onset and transient nature, and from delirium by the predominance of psychotic symptoms over cognitive disturbances.</li><li>\u27a4 Acute and Transient Psychotic Disorder</li><li>\u27a4 sudden onset of intense psychotic symptoms</li><li>\u27a4 short-lived, lasting from a few days to less than a month.</li><li>\u27a4 Ref : Shorter Oxford Textbook of Psychiatry, 7th edition, Page 272-273.</li><li>\u27a4 Ref</li><li>\u27a4 : Shorter Oxford Textbook of Psychiatry, 7th edition, Page 272-273.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e9797f99",
      "audio": ""
    },
    {
      "text": "A 52-year-old man presents with a 2-year history of persistently accusing his wife of cheating on him, despite a lack of any evidence to support his claims. He believes his wife is having multiple affairs and has gone to great lengths to track her whereabouts, even installing cameras around their home and constantly demanding that she admit to the alleged affairs. Despite the cameras never capturing any evidence and his children, who live with them, repeatedly attempting to explain the situation, he continues to hold these beliefs. The patient has no history of hallucinations or disorganized speech, and continues to be occupationally productive. Based on this presentation, which diagnosis is most likely?",
      "options": [
        {
          "label": "A",
          "text": "Schizophrenia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Schizoaffective disorder",
          "correct": false
        },
        {
          "label": "C",
          "text": "Delusional disorder",
          "correct": true
        },
        {
          "label": "D",
          "text": "Paranoid personality disorder",
          "correct": false
        }
      ],
      "correct_answer": "C. Delusional disorder",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Delusional disorder</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Schizophrenia and Option B. Schizoaffective disorder: These options are less likely due to the absence of other symptoms , such as hallucinations, disorganized speech, or negative symptoms . Additionally, the patient's overall functioning remains relatively intact, which is atypical for schizophrenia or schizoaffective disorder.</li><li>\u2022 Option A. Schizophrenia</li><li>\u2022 Option</li><li>\u2022 B. Schizoaffective disorder:</li><li>\u2022 less likely due to the absence of other symptoms</li><li>\u2022 hallucinations, disorganized speech, or negative symptoms</li><li>\u2022 Option D. Paranoid personality disorder: Paranoid personality disorder is characterized by a pattern of unjustified mistrust of others , typically beginning in early adulthood . While this disorder might share some features with delusional disorder, such as suspiciousness and mistrust, the key distinction is the presence of fixed delusions in delusional disorder.</li><li>\u2022 Option D. Paranoid personality disorder:</li><li>\u2022 characterized by a pattern of unjustified mistrust of others</li><li>\u2022 beginning in early adulthood</li><li>\u2022 Paranoid personality disorder does not involve the presence of fixed delusions , but rather a generalized pattern of suspicion and mistrust without specific, persistent beliefs .</li><li>\u2022 Paranoid personality disorder</li><li>\u2022 not involve the presence of fixed delusions</li><li>\u2022 generalized pattern of suspicion</li><li>\u2022 mistrust without specific, persistent beliefs</li><li>\u2022 Moreover, the onset of paranoid personality disorder is typically earlier in life than the patient's current age. In this case, the patient's fixed belief in his wife's infidelity, despite evidence to the contrary, and the later onset of symptoms point more towards delusional disorder than paranoid personality disorder.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Delusional Disorder is characterized by the presence of one or more delusions for at least one month . Other psychotic symptoms like hallucinations, disorganisation, and negative symptoms are usually absent . If hallucinations are present, they are for a very short duration. The individual can function relatively well in daily life except for the disturbances caused directly by the delusions.</li><li>\u2022 Delusional Disorder is characterized by the presence of one or more delusions for at least one month</li><li>\u2022 hallucinations, disorganisation, and negative symptoms are usually absent</li><li>\u2022 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 345.</li><li>\u2022 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 345.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "855ee065",
      "audio": ""
    },
    {
      "text": "A 45-year-old female presents to the psychiatric clinic with concerns about her husband. Over the past few months, she has become increasingly suspicious that her husband has been replaced by an identical-looking imposter. She insists that the person living with her is not her real spouse, although she cannot pinpoint any specific differences in appearance or behavior. She has even collected photographic evidence to prove her claim. Which of the following syndromes best describes her condition?",
      "options": [
        {
          "label": "A",
          "text": "Capgras Syndrome",
          "correct": true
        },
        {
          "label": "B",
          "text": "Fregoli Syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "Othello Syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ekbom Syndrome",
          "correct": false
        }
      ],
      "correct_answer": "A. Capgras Syndrome",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/screenshot-2024-03-12-143317.jpg"
      ],
      "explanation": "<p><strong>Ans. A) Capgras Syndrome</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Fregoli Syndrome: Fregoli Syndrome is another delusional misidentification syndrome . However, in this condition, the patient believes that a familiar person can change their physical appearance and disguise as a stranger and can take multiple different appearances . For example, a patient saw a beggar and claimed that his brother was following him in the beggar's disguise.</li><li>\u2022 Option B. Fregoli Syndrome:</li><li>\u2022 delusional misidentification syndrome</li><li>\u2022 patient believes that a familiar person can change their physical appearance and disguise as a stranger</li><li>\u2022 take multiple different appearances</li><li>\u2022 Option C. Othello Syndrome: Othello Syndrome, also known as morbid jealousy or delusional jealousy , is a psychiatric condition in which a person holds a delusional belief that their spouse or partner is being unfaithful.</li><li>\u2022 Option C. Othello Syndrome:</li><li>\u2022 morbid jealousy or delusional jealousy</li><li>\u2022 psychiatric condition</li><li>\u2022 person holds a delusional belief that their spouse or partner is being unfaithful.</li><li>\u2022 Option D. Ekbom Syndrome: Ekbom Syndrome, also known as delusional parasitosis, is a psychiatric disorder in which a person falsely believes that they are infested with parasites or insects .</li><li>\u2022 Option D. Ekbom Syndrome:</li><li>\u2022 delusional parasitosis, is a psychiatric disorder in which a person falsely believes that they are infested with parasites or insects</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Delusional misidentification syndromes include Capgras syndrome, Fregoli\u2019s syndrome, syndrome of intermetamorphosis and syndrome of subjective doubles .</li><li>\u27a4 Delusional misidentification syndromes</li><li>\u27a4 Capgras syndrome, Fregoli\u2019s syndrome, syndrome of intermetamorphosis and syndrome of subjective doubles</li><li>\u27a4 Ref : Sim\u2019s Symptoms in the Mind, 7th edition, Page No 124-125.</li><li>\u27a4 Ref</li><li>\u27a4 : Sim\u2019s Symptoms in the Mind, 7th edition, Page No 124-125.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "161007db",
      "audio": ""
    },
    {
      "text": "A third-year medical student is posted in the psychiatry department and is attending a teaching session about schizophrenia. Dr. Patel, a seasoned psychiatrist, is discussing a 25-year-old male patient recently diagnosed with schizophrenia. The patient has been experiencing auditory hallucinations, delusional thinking, and significant social withdrawal. Dr. Patel emphasizes the importance of understanding the neurotransmitter imbalances that underlie the symptoms of schizophrenia, as this understanding can guide treatment. She then poses a question to the medical student: \"Which neurotransmitters are primarily implicated in the pathophysiology of schizophrenia?\"",
      "options": [
        {
          "label": "A",
          "text": "Acetylcholine and norepinephrine.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Endorphins and enkephalins.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Dopamine and serotonin.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Histamine and oxytocin.",
          "correct": false
        }
      ],
      "correct_answer": "C. Dopamine and serotonin.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Dopamine and serotonin.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Acetylcholine and norepinephrine: There is some evidence pointing to their involvement in schizophrenia. However, the dopamine and serotonin systems are more classically associated with the disease .</li><li>\u2022 Option A: Acetylcholine and norepinephrine:</li><li>\u2022 dopamine and serotonin systems are more classically associated with the disease</li><li>\u2022 Option B: Endorphins and enkephalins: These are endogenous opioids , not primarily associated with schizophrenia's pathophysiology.</li><li>\u2022 Option B: Endorphins and enkephalins:</li><li>\u2022 endogenous opioids</li><li>\u2022 Option D: Histamine and oxytocin: While there's ongoing research into their roles in various conditions, they aren't the primary neurotransmitters implicated in schizophrenia .</li><li>\u2022 Option D: Histamine and oxytocin:</li><li>\u2022 they aren't the primary neurotransmitters implicated in schizophrenia</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Dopamine hypothesis proposes that excess of dopaminergic activity is responsible for schizophrenia . Along with dopamine, an excess of serotonin is also considered to be responsible for the development of schizophrenia. Other neurotransmitters such as GABA, glutamate, norepinephrine, acetylcholine, nicotine have also been implicated in pathogenesis of schizophrenia.</li><li>\u27a4 Dopamine hypothesis</li><li>\u27a4 excess of dopaminergic activity</li><li>\u27a4 schizophrenia</li><li>\u27a4 excess of serotonin</li><li>\u27a4 neurotransmitters such as GABA, glutamate, norepinephrine, acetylcholine, nicotine</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 361.</li><li>\u27a4 Ref:</li><li>\u27a4 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 361.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4cdbcdef",
      "audio": ""
    },
    {
      "text": "A 45-year-old patient with a longstanding diagnosis of schizophrenia has been participating in a research study to investigate the neural correlates of the disease. The patient has a prominent history of auditory hallucinations. A magnetic resonance imaging (MRI) scan of the brain is performed. Based on the patient's clinical presentation and the area of the brain commonly associated with these symptoms, which cerebral lobe is most likely to show atrophy in this case?",
      "options": [
        {
          "label": "A",
          "text": "Frontal lobe",
          "correct": false
        },
        {
          "label": "B",
          "text": "Occipital lobe",
          "correct": false
        },
        {
          "label": "C",
          "text": "Parietal lobe",
          "correct": false
        },
        {
          "label": "D",
          "text": "Temporal lobe",
          "correct": true
        }
      ],
      "correct_answer": "D. Temporal lobe",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Temporal lobe</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Structural and functional abnormalities in the temporal lobe, particularly the superior temporal gyrus, are strongly linked to auditory hallucinations in schizophrenia.</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "507b9549",
      "audio": ""
    },
    {
      "text": "A 22-year-old man is brought to the psychiatric outpatient department by his concerned parents. They noticed that, over the past few weeks, he has been repeatedly rubbing his forearms and often appears distressed. When asked about this behavior, the patient hesitantly shares that he feels cold sensations running down his forearms. He believes that these sensations are not natural and are deliberately being inflicted upon him by the neighbors living next door. Based on Schneider\u2019s first rank symptoms, which one best describes the patient's experience?",
      "options": [
        {
          "label": "A",
          "text": "Delusion of persecution",
          "correct": false
        },
        {
          "label": "B",
          "text": "Somatic passivity",
          "correct": true
        },
        {
          "label": "C",
          "text": "Thought insertion",
          "correct": false
        },
        {
          "label": "D",
          "text": "Thought withdrawal",
          "correct": false
        }
      ],
      "correct_answer": "B. Somatic passivity",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/screenshot-2024-03-12-143457.jpg"
      ],
      "explanation": "<p><strong>Ans. B) Somatic passivity.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Delusion of persecution: This involves a belief that one is going to be harmed, harassed , and so forth by an individual , organization, or other group.</li><li>\u2022 Option A: Delusion of persecution:</li><li>\u2022 involves a belief that one is going to be harmed, harassed</li><li>\u2022 forth by an individual</li><li>\u2022 Option C: Thought insertion: Here, the patient feels that some external agency is inserting foreign thoughts into his/her mind.</li><li>\u2022 Option C: Thought insertion:</li><li>\u2022 patient feels that some external agency is inserting foreign thoughts into his/her mind.</li><li>\u2022 Option D: Thought withdrawal: Patient experiences that his thoughts are being withdrawn from his/her mind by an external force .</li><li>\u2022 Option D: Thought withdrawal:</li><li>\u2022 his thoughts are being withdrawn from his/her mind by an external force</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: A Short Textbook of Psychiatry, 7th edition, Page No 55.</li><li>\u27a4 Ref:</li><li>\u27a4 A Short Textbook of Psychiatry, 7th edition, Page No 55.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9ccabf86",
      "audio": ""
    },
    {
      "text": "A 23-year-old individual has been brought to the psychiatric clinic by their family due to increasingly bizarre behavior and disordered thinking observed over the last six months. The patient reports experiencing episodes where their emotions feel controlled by an external force, causing significant distress. The mental status examination does not reveal any prominent mood disorder symptoms, and there is no history of substance abuse. Based on these clinical features, which of the following is most likely a first-rank symptom of schizophrenia in this patient's presentation?",
      "options": [
        {
          "label": "A",
          "text": "Autism",
          "correct": false
        },
        {
          "label": "B",
          "text": "Made affect",
          "correct": true
        },
        {
          "label": "C",
          "text": "Association disturbances",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ambivalency",
          "correct": false
        }
      ],
      "correct_answer": "B. Made affect",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Made affect</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In made affect, the patient experiences that someone is controlling his/her affect (emotions). It is consistent with the first-rank symptoms of schizophrenia described by Kurt Schneider.</li><li>\u27a4 Ref : A Short Textbook of Psychiatry, 7th edition.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f4d958d2",
      "audio": ""
    },
    {
      "text": "A 25-year-old woman is referred to a psychiatric clinic following several instances of disturbed behavior. Recently, after the unexpected death of her mother, she began reporting auditory hallucinations, particularly voices of the devil and has grown increasingly paranoid, fearing harm from those around her. Detailed assessment uncovers a gradual 3-year decline characterized by her distancing from friends, displaying apathy, and exhibiting odd behaviors, like collecting rainwater to \"ward off spirits\". Her father had been treated for major depression. Based on her history, which aspect suggests a potentially unfavorable prognosis for her schizophrenia?",
      "options": [
        {
          "label": "A",
          "text": "Her gender being female.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Receiving her diagnosis at the age of 25.",
          "correct": false
        },
        {
          "label": "C",
          "text": "The sudden stressor (mother's death) preceding auditory hallucinations.",
          "correct": false
        },
        {
          "label": "D",
          "text": "The slow, progressive onset of her symptoms.",
          "correct": true
        }
      ],
      "correct_answer": "D. The slow, progressive onset of her symptoms.",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/screenshot-2024-03-12-144108.jpg"
      ],
      "explanation": "<p><strong>Ans. D) She had an insidious onset of her illness.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: She is female: Female gender is generally associated with a better prognosis in schizophrenia.</li><li>\u2022 Option A: She is female:</li><li>\u2022 Female gender</li><li>\u2022 associated with a better prognosis</li><li>\u2022 Option B: She was age 25 at diagnosis: A younger age at the time of diagnosis (e.g., adolescence) is often associated with a poorer prognosis . Age 25 is not necessarily indicative of a particularly poor prognosis.</li><li>\u2022 Option B: She was age 25 at diagnosis:</li><li>\u2022 younger age</li><li>\u2022 associated with a poorer prognosis</li><li>\u2022 Option C: She had an acute precipitating factor before she began hearing voices: An acute onset of symptoms after a significant stressor or life event tends to be associated with a better prognosis. In this patient, the death of her mother could be such a precipitating factor.</li><li>\u2022 Option C: She had an acute precipitating factor before she began hearing voices:</li><li>\u2022 acute onset of symptoms after a significant stressor</li><li>\u2022 life event tends to be associated with a better prognosis.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 An insidious onset , prominent negative symptoms , poor premorbid adjustment , and absence of precipitating factors are among features typically associated with a worse prognosis in schizophrenia.</li><li>\u2022 insidious onset</li><li>\u2022 prominent negative symptoms</li><li>\u2022 poor premorbid adjustment</li><li>\u2022 absence of precipitating factors</li><li>\u2022 associated with a worse prognosis in schizophrenia.</li><li>\u2022 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 350.</li><li>\u2022 Ref:</li><li>\u2022 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 350.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "440a9ed1",
      "audio": ""
    },
    {
      "text": "Which of the following is not true regarding schizophrenia?",
      "options": [
        {
          "label": "A",
          "text": "Homicide is the most common cause of premature death",
          "correct": true
        },
        {
          "label": "B",
          "text": "Lifetime prevalence is 0.7 %",
          "correct": false
        },
        {
          "label": "C",
          "text": "Catatonic schizophrenia is associated with the best prognosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Negative symptoms are associated with poor prognosis",
          "correct": false
        }
      ],
      "correct_answer": "A. Homicide is the most common cause of premature death",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Homicide is the most common cause of premature death</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Suicide is the most common cause of premature death in persons suffering from schizophrenia. 10% of patients with schizophrenia die by suicide (DSM-5 figure: 5-6%)</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3519b4ad",
      "audio": ""
    },
    {
      "text": "A 26-year-old female presents to the psychiatric clinic complaining of a progressively declining interest in attending her job over the past month. Upon review of her medical records, it is noted that she has previously been treated with risperidone and demonstrated significant clinical improvement. She currently denies any auditory or visual hallucinations. Physical examination shows no evidence of tremor, rigidity, or bradykinesia. Based on the patient's history and presentation, which of the following is the MOST likely explanation for her decreased interest in work?",
      "options": [
        {
          "label": "A",
          "text": "Drug-induced Parkinsonism",
          "correct": false
        },
        {
          "label": "B",
          "text": "Negative symptoms of a psychiatric disorder",
          "correct": true
        },
        {
          "label": "C",
          "text": "Depression",
          "correct": false
        },
        {
          "label": "D",
          "text": "Reaction to active hallucinations",
          "correct": false
        }
      ],
      "correct_answer": "B. Negative symptoms of a psychiatric disorder",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Negative symptoms of a psychiatric disorder</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Negative symptoms represent \u201closs of normal functions\u201d in patients with  These symptoms respond poorly to medications and thus their presence is a bad prognostic factor. They occur due to decreased dopamine activity in mesocortical pathway. While anhedonia (loss of pleasure in previously pleasurable activities) is a symptom of both depression and schizophrenia, the absence of other key depressive symptoms and the history of treatment with an antipsychotic make negative symptoms of schizophrenia more likely.</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "965002f0",
      "audio": ""
    },
    {
      "text": "A 35-year-old patient diagnosed with schizophrenia is being evaluated for a change in their medication regimen. The healthcare provider is considering various antipsychotic medications and wants to choose a typical (first generation) antipsychotic for this patient. Based on the medications listed, which of the following are classified as typical antipsychotics? Fluphenazine Risperidone Pimozide Aripiprazole Olanzapine",
      "options": [
        {
          "label": "A",
          "text": "1, 2, 3",
          "correct": false
        },
        {
          "label": "B",
          "text": "1, 3",
          "correct": true
        },
        {
          "label": "C",
          "text": "2, 3",
          "correct": false
        },
        {
          "label": "D",
          "text": "4, 5",
          "correct": false
        }
      ],
      "correct_answer": "B. 1, 3",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/flow-chart-1.jpg"
      ],
      "explanation": "<p><strong>Ans. B) 1, 3</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Fluphenazine and 3. Pimozide are typical antipsychotics. Typical antipsychotics, also known as first-generation antipsychotics, are older antipsychotic drugs that primarily work by blocking dopamine D2 receptors , which can be effective in treating positive symptoms of schizophrenia, such as delusions and hallucinations. However, they can have significant extrapyramidal side effects and tardive dyskinesia. The other drugs listed are considered atypical or second-generation antipsychotics: Risperidone: While risperidone is considered an atypical antipsychotic , it is known for its higher risk of extrapyramidal side effects among the atypical antipsychotics. Aripiprazole: This is an atypical antipsychotic with a unique mechanism of action as a dopamine partial agonist. Olanzapine: This is another atypical antipsychotic , which has a lower risk of extrapyramidal side effects , although it carries a risk of metabolic side effects like weight gain and increased blood sugar levels.</li><li>\u2022 Fluphenazine and 3. Pimozide are typical antipsychotics. Typical antipsychotics, also known as first-generation antipsychotics, are older antipsychotic drugs that primarily work by blocking dopamine D2 receptors , which can be effective in treating positive symptoms of schizophrenia, such as delusions and hallucinations. However, they can have significant extrapyramidal side effects and tardive dyskinesia. The other drugs listed are considered atypical or second-generation antipsychotics:</li><li>\u2022 Fluphenazine and 3. Pimozide</li><li>\u2022 antipsychotics.</li><li>\u2022 first-generation antipsychotics,</li><li>\u2022 older antipsychotic drugs</li><li>\u2022 work by blocking dopamine D2 receptors</li><li>\u2022 effective in treating positive symptoms of schizophrenia,</li><li>\u2022 Risperidone: While risperidone is considered an atypical antipsychotic , it is known for its higher risk of extrapyramidal side effects among the atypical antipsychotics.</li><li>\u2022 Risperidone:</li><li>\u2022 atypical antipsychotic</li><li>\u2022 higher risk of extrapyramidal side effects</li><li>\u2022 Aripiprazole: This is an atypical antipsychotic with a unique mechanism of action as a dopamine partial agonist.</li><li>\u2022 Aripiprazole:</li><li>\u2022 atypical antipsychotic</li><li>\u2022 unique mechanism of action</li><li>\u2022 Olanzapine: This is another atypical antipsychotic , which has a lower risk of extrapyramidal side effects , although it carries a risk of metabolic side effects like weight gain and increased blood sugar levels.</li><li>\u2022 Olanzapine:</li><li>\u2022 atypical antipsychotic</li><li>\u2022 has a lower risk of extrapyramidal side effects</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 618.</li><li>\u27a4 Ref:</li><li>\u27a4 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 618.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c1af4665",
      "audio": ""
    },
    {
      "text": "A 60-year-old woman with a chronic mental disorder comes to the physician with irregular choreoathetoid movements of her hands and trunk. She states that the movements get worse under stressful conditions. Which of the following medications is most likely to have caused this disorder?",
      "options": [
        {
          "label": "A",
          "text": "Sertraline",
          "correct": false
        },
        {
          "label": "B",
          "text": "Clozapine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Diazepam",
          "correct": false
        },
        {
          "label": "D",
          "text": "Risperidone",
          "correct": true
        }
      ],
      "correct_answer": "D. Risperidone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Risperidone.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Sertraline: An SSRI antidepressant mainly used for depression and various anxiety disorders . It is not primarily associated with tardive dyskinesia.</li><li>\u2022 Option A: Sertraline:</li><li>\u2022 used for depression and various anxiety disorders</li><li>\u2022 Option B: Clozapine: An atypical antipsychotic that is least likely to cause tardive dyskinesia compared to other antipsychotic medications . In fact, clozapine can sometimes reduce TD that is caused by other antipsychotic medications.</li><li>\u2022 Option B: Clozapine:</li><li>\u2022 atypical antipsychotic</li><li>\u2022 least likely to cause tardive dyskinesia compared to other antipsychotic medications</li><li>\u2022 Option C: Diazepam: A benzodiazepine primarily used for anxiety, seizures, and muscle spasms . It is not associated with the development of tardive dyskinesia.</li><li>\u2022 Option C: Diazepam:</li><li>\u2022 anxiety, seizures, and muscle spasms</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Tardive dyskinesia develops after long-term treatment with antipsychotics and is characterized by involuntary choreoathetoid movements of the tongue, jaw, lips, trunk or extremities . Risk factors for developing TD include older age, female sex, and long duration of antipsychotic use . The primary prevention of TD involves using the lowest effective dose of antipsychotic and regularly monitoring patients. If a patient develops symptoms of TD, it's important to consider discontinuing the antipsychotic or switching to one with a lower risk for TD, such as clozapine.</li><li>\u2022 Tardive dyskinesia</li><li>\u2022 long-term treatment with antipsychotics and is characterized by involuntary choreoathetoid movements of the tongue, jaw, lips, trunk or extremities</li><li>\u2022 older age, female sex, and long duration of antipsychotic use</li><li>\u2022 Ref: The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 110-111.</li><li>\u2022 Ref:</li><li>\u2022 The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 110-111.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cc415889",
      "audio": ""
    },
    {
      "text": "Regarding depot preparations, which of the following statements is FALSE?",
      "options": [
        {
          "label": "A",
          "text": "Depot medications are useful in cases of non-compliance",
          "correct": false
        },
        {
          "label": "B",
          "text": "They undergo less first-pass metabolism than oral preparations",
          "correct": false
        },
        {
          "label": "C",
          "text": "Injection site reactions are a side-effect",
          "correct": false
        },
        {
          "label": "D",
          "text": "All antipsychotic depot preparations are oil based",
          "correct": true
        }
      ],
      "correct_answer": "D. All antipsychotic depot preparations are oil based",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) All antipsychotic depot preparations are oil based.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Depot medications are useful in cases of non-compliance: This is true . Depot antipsychotics are particularly useful in managing patients who have difficulty adhering to oral medication regimens.</li><li>\u2022 Option A: Depot medications are useful in cases of non-compliance:</li><li>\u2022 true</li><li>\u2022 Option B: They undergo less first-pass metabolism than oral preparations: This is also true . Depot injections bypass the gastrointestinal tract and thus avoid first-pass metabolism in the liver. This can result in more stable and predictable pharmacokinetics.</li><li>\u2022 Option B: They undergo less first-pass metabolism than oral preparations:</li><li>\u2022 true</li><li>\u2022 Option C: Injection site reactions are a side-effect: This is true . Injection site reactions, such as pain, redness, and swelling, are potential side effects of depot antipsychotic medications.</li><li>\u2022 Option C: Injection site reactions are a side-effect:</li><li>\u2022 true</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Depot antipsychotic preparations are useful for ensuring compliance , especially in patients who may have difficulty adhering to a daily oral regimen . The patients typically receive the intramuscular injections of antipsychotics once a month or once in a fortnight.</li><li>\u2022 Depot antipsychotic preparations</li><li>\u2022 ensuring compliance</li><li>\u2022 patients who may have difficulty adhering to a daily oral regimen</li><li>\u2022 intramuscular injections</li><li>\u2022 Ref: The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 67.</li><li>\u2022 Ref:</li><li>\u2022 The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 67.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c7f54f06",
      "audio": ""
    },
    {
      "text": "The most probable diagnosis in a clozapine-treated patient who has persistent tachycardia, fatigue, fever, and eosinophilia is:",
      "options": [
        {
          "label": "A",
          "text": "Pulmonary embolism",
          "correct": false
        },
        {
          "label": "B",
          "text": "Paralytic ileus",
          "correct": false
        },
        {
          "label": "C",
          "text": "Agranulocytosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Myocarditis",
          "correct": true
        }
      ],
      "correct_answer": "D. Myocarditis",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/screenshot-2024-03-12-144402.jpg"
      ],
      "explanation": "<p><strong>Ans. D) Myocarditis.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Pulmonary embolism: While this can cause tachycardia and fatigue , it is not typically associated with fever and eosinophilia.</li><li>\u2022 Option A: Pulmonary embolism:</li><li>\u2022 cause tachycardia and fatigue</li><li>\u2022 not typically associated with fever and eosinophilia.</li><li>\u2022 Option B: Paralytic ileus: This would primarily present with symptoms related to bowel obstruction such as abdominal distension and constipation. It's not associated with tachycardia, fever, and eosinophilia.</li><li>\u2022 Option B: Paralytic ileus:</li><li>\u2022 symptoms related to bowel obstruction such as abdominal distension and constipation.</li><li>\u2022 Option C: Agranulocytosis: This is a well-known side effect of clozapine , but it presents with a decrease in white blood cells , especially neutrophils , and would not cause eosinophilia. Patients with agranulocytosis may have fever, sore throat, and increased susceptibility to infections.</li><li>\u2022 Option C: Agranulocytosis:</li><li>\u2022 well-known side effect of clozapine</li><li>\u2022 decrease in white blood cells</li><li>\u2022 neutrophils</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Clozapine is the drug of choice in treatment-resistant schizophrenia. It has strong affinity towards D4 and low affinity towards D2 , which explains the lack of extrapyramidal side effects . It also acts as an antagonist at 5 HT2A, D1, D3 and \u237a -adrenergic receptors. Clozapine is the only antipsychotic that decreases the suicidal ideation .</li><li>\u2022 Clozapine is the drug of choice in treatment-resistant schizophrenia.</li><li>\u2022 strong affinity towards D4 and low affinity towards D2</li><li>\u2022 lack of extrapyramidal side effects</li><li>\u2022 decreases</li><li>\u2022 suicidal ideation</li><li>\u2022 Ref: The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 222-224.</li><li>\u2022 Ref:</li><li>\u2022 The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 222-224.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "221ff70c",
      "audio": ""
    },
    {
      "text": "A 29-year-old woman with a history of Schizophrenia is being seen in the clinic for a medication review. She has been stable on her current medication but is concerned about her recent weight gain of 15 pounds over the past 6 months. She is conscious about her weight and does not want any medication that might exacerbate this issue. She inquires about potential antipsychotic medications that might be less likely to cause weight gain. Which of the following antipsychotics would be the best recommendation for this patient if considering the potential for weight gain?",
      "options": [
        {
          "label": "A",
          "text": "Aripiprazole",
          "correct": true
        },
        {
          "label": "B",
          "text": "Olanzapine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Quetiapine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Risperidone",
          "correct": false
        }
      ],
      "correct_answer": "A. Aripiprazole",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/flow-chart-2_WYr6DHY.jpg"
      ],
      "explanation": "<p><strong>Ans. A) Aripiprazole.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: Olanzapine: Associated with significant weight gain , as well as other metabolic side effects.</li><li>\u2022 Option B: Olanzapine:</li><li>\u2022 significant weight gain</li><li>\u2022 Option C: Quetiapine: Can cause moderate weight gain , though not as much as olanzapine.</li><li>\u2022 Option C: Quetiapine:</li><li>\u2022 moderate weight gain</li><li>\u2022 Option D: Risperidone: Can also lead to weight gain , but generally less than olanzapine and quetiapine.</li><li>\u2022 Option D: Risperidone:</li><li>\u2022 lead to weight gain</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 PATHOPHYSIOLOGY OF ANTIPSYCHOTIC INDUCED WEIGHT GAIN</li><li>\u2022 PATHOPHYSIOLOGY OF ANTIPSYCHOTIC INDUCED WEIGHT GAIN</li><li>\u2022 Aripiprazole and ziprasidone are two antipsychotics with a relatively lower risk of weight gain compared to others . Olanzapine and clozapine are most associated with weight gain.</li><li>\u2022 Aripiprazole</li><li>\u2022 ziprasidone</li><li>\u2022 two antipsychotics</li><li>\u2022 lower risk of weight gain compared to others</li><li>\u2022 Ref: The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 123.</li><li>\u2022 Ref:</li><li>\u2022 The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 123.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "805f11db",
      "audio": ""
    },
    {
      "text": "A 20-year-old woman is brought to the emergency room by her family because they have been unable to get her to eat or drink anything for the past 2 days. The patient, although awake, is completely unresponsive both vocally and nonverbally. She actively resists any attempt to be moved. Her family reports that during the previous 7 months she became increasingly withdrawn, socially isolated, and bizarre; often speaking to people no one else could see. Which of the following is the treatment of choice for the above condition?",
      "options": [
        {
          "label": "A",
          "text": "Intravenous Lorazepam",
          "correct": true
        },
        {
          "label": "B",
          "text": "ECT",
          "correct": false
        },
        {
          "label": "C",
          "text": "Olanzapine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Escitalopram",
          "correct": false
        }
      ],
      "correct_answer": "A. Intravenous Lorazepam",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Intravenous Lorazepam</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: Electroconvulsive Therapy (ECT): ECT is a treatment of choice for catatonia that is refractory to benzodiazepines, but it is not typically the first-line treatment.</li><li>\u2022 Option B: Electroconvulsive Therapy (ECT):</li><li>\u2022 treatment of choice for catatonia</li><li>\u2022 refractory to benzodiazepines,</li><li>\u2022 Option C: Olanzapine: While olanzapine is effective in treating underlying psychotic disorders , it is not the first-line treatment for acute catatonic episodes . Infact, antipsychotics should be avoided in catatonic patients.</li><li>\u2022 Option C: Olanzapine:</li><li>\u2022 effective in treating underlying psychotic disorders</li><li>\u2022 not the first-line treatment for acute catatonic episodes</li><li>\u2022 Option D: Escitalopram: Escitalopram is primarily used for depression and anxiety disorders; it is not indicated in the acute management of catatonia.</li><li>\u2022 Option D: Escitalopram:</li><li>\u2022 primarily used for depression and anxiety disorders;</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Intravenous lorazepam is the first-line treatment for catatonia . Lorazepam acts by increasing GABAergic neurotransmission and reducing the levels of BDNF . It is effective in rapidly reducing the symptoms of catatonia , which can include mutism, immobility, and resistance to movement. Once the catatonic state is managed, further treatment should focus on the underlying psychiatric condition.</li><li>\u27a4 Intravenous lorazepam</li><li>\u27a4 first-line treatment for catatonia</li><li>\u27a4 Lorazepam</li><li>\u27a4 increasing GABAergic neurotransmission and reducing the levels of BDNF</li><li>\u27a4 effective</li><li>\u27a4 rapidly reducing the symptoms of catatonia</li><li>\u27a4 mutism, immobility, and resistance to movement.</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 11th edition, Page No 346.</li><li>\u27a4 Ref:</li><li>\u27a4 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 11th edition, Page No 346.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c9dcdc75",
      "audio": ""
    },
    {
      "text": "A 23-year-old male presents to the outpatient clinic for a follow-up visit. He was diagnosed with schizophrenia 2 months ago after experiencing auditory hallucinations and delusional beliefs. His symptoms have significantly improved with risperidone, and he currently reports feeling more \"like himself\" again. His family and social histories are unremarkable, with no known relatives with psychiatric disorders. The patient, eager to move on with his life, inquires about the duration for which he will need to continue his medication. What is the recommended treatment duration for this patient?",
      "options": [
        {
          "label": "A",
          "text": "5 years",
          "correct": false
        },
        {
          "label": "B",
          "text": "2 years",
          "correct": false
        },
        {
          "label": "C",
          "text": "6 months",
          "correct": false
        },
        {
          "label": "D",
          "text": "1 year",
          "correct": true
        }
      ],
      "correct_answer": "D. 1 year",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) 1 years.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ef6a67f3",
      "audio": ""
    },
    {
      "text": "A 40-year-old patient with a history of psychosis is brought to the medical attention due to the exhibition of erratic behavior, characterized by purposeless movements. Additionally, the healthcare team observes episodes where the patient remains immobile for prolonged durations. Upon physical examination, the patient demonstrates negativism and waxy flexibility. Based on these clinical findings, what is the most appropriate pharmacological intervention for managing this patient's condition?",
      "options": [
        {
          "label": "A",
          "text": "Haloperidol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Clonidine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Propranolol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lorazepam",
          "correct": true
        }
      ],
      "correct_answer": "D. Lorazepam",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Lorazepam</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Haloperidol is an antipsychotic medication that could potentially exacerbate catatonic symptoms and is generally avoided, especially in the initial management of catatonia.</li><li>\u2022 Option A: Haloperidol</li><li>\u2022 antipsychotic medication</li><li>\u2022 potentially exacerbate catatonic symptoms</li><li>\u2022 Option B: Clonidine is an alpha-2 adrenergic agonist primarily used for treating hypertension and is not indicated for the treatment of catatonia.</li><li>\u2022 Option B: Clonidine</li><li>\u2022 alpha-2 adrenergic agonist</li><li>\u2022 treating hypertension</li><li>\u2022 Option C: Propranolol is a beta-blocker used for treating hypertension, anxiety, and akathisia but is not the treatment of choice for catatonia.</li><li>\u2022 Option C: Propranolol</li><li>\u2022 beta-blocker used for treating hypertension, anxiety, and akathisia</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The term catatonia was given by Karl Kahlbaum . Catatonia is a psychiatric emergency that is characterized by severe motor abnormalities such as akinetic mutism (stupor), excitement , waxy flexibility , posturing , catalepsy , automatic obedience , negativism , Gegenhalten , psychological pillow etc. The lorazepam challenge test aids in prompt diagnosis. Lorazepam is first line treatment for catatonia.</li><li>\u27a4 catatonia</li><li>\u27a4 Karl Kahlbaum</li><li>\u27a4 psychiatric emergency</li><li>\u27a4 severe motor abnormalities</li><li>\u27a4 akinetic mutism</li><li>\u27a4 excitement</li><li>\u27a4 waxy flexibility</li><li>\u27a4 posturing</li><li>\u27a4 catalepsy</li><li>\u27a4 automatic obedience</li><li>\u27a4 negativism</li><li>\u27a4 Gegenhalten</li><li>\u27a4 Lorazepam</li><li>\u27a4 first line treatment</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 11th edition, Page No 345-346.</li><li>\u27a4 Ref:</li><li>\u27a4 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 11th edition, Page No 345-346.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1c7614a7",
      "audio": ""
    },
    {
      "text": "The lorazepam challenge test is used in the diagnosis of?",
      "options": [
        {
          "label": "A",
          "text": "Dissociative amnesia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Transient global amnesia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Catatonia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Panic disorder",
          "correct": false
        }
      ],
      "correct_answer": "C. Catatonia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Catatonia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Dissociative amnesia: Diagnosed clinically based on the inability to recall important personal information , usually of a traumatic or stressful nature.</li><li>\u2022 Option A: Dissociative amnesia:</li><li>\u2022 clinically based on the inability to recall important personal information</li><li>\u2022 Option B: Transient global amnesia: A sudden, temporary episode of memory loss ; diagnosis is clinical, based on history and exclusion of other conditions.</li><li>\u2022 Option B: Transient global amnesia:</li><li>\u2022 temporary episode of memory loss</li><li>\u2022 Option D: Panic disorder: Diagnosed based on recurrent , unexpected panic attacks and the fear of further attacks.</li><li>\u2022 Option D: Panic disorder:</li><li>\u2022 based on recurrent</li><li>\u2022 unexpected panic attacks</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 The lorazepam challenge test is used in the diagnosis of catatonia . It involves administering lorazepam intravenously (1-2 mg) and observing for a reduction in catatonic symptoms , which usually takes 30 minutes .  It can aid the diagnosis and guide subsequent treatment.</li><li>\u2022 lorazepam challenge test</li><li>\u2022 diagnosis of catatonia</li><li>\u2022 administering lorazepam intravenously</li><li>\u2022 reduction in catatonic symptoms</li><li>\u2022 takes 30 minutes</li><li>\u2022 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 11th edition, Page No 345-346.</li><li>\u2022 Ref:</li><li>\u2022 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 11th edition, Page No 345-346.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3848fa51",
      "audio": ""
    },
    {
      "text": "A 30-year-old man presents to the emergency department displaying disorganized behavior. He was discovered walking barefoot in the middle of the night. Upon admission to the psychiatric ward and initiation of antipsychotic therapy, his symptoms stabilized. A review of his medical records reveals a consistent pattern: he regularly discontinues his prescribed antipsychotic medications after discharge, leading to a relapse of symptoms within 6 months. To optimize his treatment and reduce the likelihood of noncompliance, which medication would be most appropriate for maintenance therapy?",
      "options": [
        {
          "label": "A",
          "text": "Clozapine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Haloperidol decanoate",
          "correct": true
        },
        {
          "label": "C",
          "text": "Chlorpromazine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Thioridazine",
          "correct": false
        }
      ],
      "correct_answer": "B. Haloperidol decanoate",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Haloperidol decanoate</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Clozapine: It is reserved for treatment-resistant schizophrenia . While effective, it is not a long-acting injectable.</li><li>\u2022 Option A. Clozapine:</li><li>\u2022 reserved for treatment-resistant schizophrenia</li><li>\u2022 Option C. Chlorpromazine and Option D. Thioridazine: Both are oral typical antipsychotics and do not offer the advantage of extended dosing intervals like the long-acting injectables.</li><li>\u2022 Option C. Chlorpromazine and Option D. Thioridazine:</li><li>\u2022 oral typical antipsychotics</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Depot antipsychotics (long-acting injectable antipsychotics) are indicated in patients with poor compliance to medications. The patients typically receive the intramuscular injections of antipsychotics once a month or once a fortnight. Intramuscular injection is given using the Z track technique . Long-acting injectable antipsychotics available are:</li><li>\u2022 poor compliance</li><li>\u2022 intramuscular injections</li><li>\u2022 Z track technique</li><li>\u2022 Flupenthixol Fluphenazine Haloperidol Pipotiazine Zuclopenthixol Risperdione Olanzapine Paliperidone Aripiprazole</li><li>\u2022 Flupenthixol</li><li>\u2022 Fluphenazine</li><li>\u2022 Haloperidol</li><li>\u2022 Pipotiazine</li><li>\u2022 Zuclopenthixol</li><li>\u2022 Risperdione</li><li>\u2022 Olanzapine</li><li>\u2022 Paliperidone</li><li>\u2022 Aripiprazole</li><li>\u2022 Ref: The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 67.</li><li>\u2022 Ref:</li><li>\u2022 The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 67.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "94ca3c0a",
      "audio": ""
    },
    {
      "text": "In clinical practice, the Z-tracking technique is a specific method employed for a particular type of intervention. Which of the following scenarios is the Z-tracking technique most commonly used?",
      "options": [
        {
          "label": "A",
          "text": "Administering long acting antipsychotic",
          "correct": true
        },
        {
          "label": "B",
          "text": "Lithium monitoring",
          "correct": false
        },
        {
          "label": "C",
          "text": "Carbamazepine monitoring",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nicotine patch",
          "correct": false
        }
      ],
      "correct_answer": "A. Administering long acting antipsychotic",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Administering long acting antipsychotic</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: Lithium monitoring refers to the regular blood tests required to check lithium levels in patients taking lithium for mood stabilization , particularly in bipolar disorder. The Z-track method is not applicable in this scenario.</li><li>\u2022 Option B: Lithium monitoring</li><li>\u2022 regular blood tests required to check lithium levels in patients taking lithium for mood stabilization</li><li>\u2022 Option C: Carbamazepine monitoring is similar to lithium monitoring in that it involves blood tests to monitor medication levels and ensure they are within the therapeutic range . Again, the Z-track method is not used in this context.</li><li>\u2022 Option C: Carbamazepine monitoring</li><li>\u2022 lithium monitoring</li><li>\u2022 involves blood tests to monitor medication levels</li><li>\u2022 ensure they are within the therapeutic range</li><li>\u2022 Option D: Nicotine patch refers to a transdermal patch used to deliver nicotine as part of smoking cessation therapy. The Z-track technique is not relevant to the application of transdermal patches.</li><li>\u2022 Option D: Nicotine patch</li><li>\u2022 transdermal patch used to deliver nicotine as part of smoking cessation therapy.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Z-track technique is a method used to administer intramuscular injections , which is particularly useful for medications that can be irritating to subcutaneous tissue or have the potential to discolor the skin . It also prevents the medication from leaking into the patient\u2019s subcutaneous tissue which can cause erratic absorption . It involves pulling the skin and subcutaneous tissues to one side before inserting the needle into the muscle . After injecting the medication, the needle is removed, and the skin is released, creating a zigzag path that seals the medication in the muscle and prevents it from leaking into the subcutaneous tissue. This technique is most commonly used for administering depot antipsychotics.</li><li>\u27a4 Z-track technique is a method used to administer intramuscular injections</li><li>\u27a4 particularly useful for medications</li><li>\u27a4 irritating to subcutaneous tissue</li><li>\u27a4 potential to discolor the skin</li><li>\u27a4 prevents the medication from leaking into the patient\u2019s subcutaneous tissue</li><li>\u27a4 erratic absorption</li><li>\u27a4 pulling the skin and subcutaneous tissues</li><li>\u27a4 one side before inserting the needle into the muscle</li><li>\u27a4 depot antipsychotics.</li><li>\u27a4 Ref: The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 67.</li><li>\u27a4 Ref:</li><li>\u27a4 The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 67.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f0308eae",
      "audio": ""
    },
    {
      "text": "A 21-year-old man is brought to the clinic by his mother, who reports a sudden and concerning change in his posture. The boy was recently started on an antipsychotic medication by his psychiatrist. On examination, you observe that his head and neck are twisted to one side, resembling a torticollis. His vitals are stable, and no other neurological or systemic symptoms are present. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Acute dystonia",
          "correct": true
        },
        {
          "label": "B",
          "text": "Akathisia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Neuroleptic malignant syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tardive dyskinesia",
          "correct": false
        }
      ],
      "correct_answer": "A. Acute dystonia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Acute dystonia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: Akathisia is a subjective feeling of inner restlessness along with objective signs of restlessness such as fidgeting of legs , pacing around , and inability to sit or stand in one place for a long time. It doesn't manifest as torticollis.</li><li>\u2022 Option B:</li><li>\u2022 Akathisia</li><li>\u2022 subjective feeling of inner restlessness</li><li>\u2022 objective signs of restlessness such as fidgeting of legs</li><li>\u2022 pacing around</li><li>\u2022 inability to sit or stand</li><li>\u2022 Option C: Neuroleptic malignant syndrome is a life-threatening reaction to antipsychotic drugs characterized by fever, autonomic instability, altered mental status, and generalized muscle rigidity . It doesn't typically present solely with torticollis.</li><li>\u2022 Option C:</li><li>\u2022 Neuroleptic malignant syndrome</li><li>\u2022 life-threatening reaction to antipsychotic drugs</li><li>\u2022 fever, autonomic instability, altered mental status, and generalized muscle rigidity</li><li>\u2022 Option D: Tardive dyskinesia is a late-onset EPS , which presents as involuntary, repetitive movements, often of the mouth, lips, and tongue . It usually occurs after prolonged use of antipsychotic medications and not shortly after the initiation of therapy.</li><li>\u2022 Option D:</li><li>\u2022 Tardive dyskinesia</li><li>\u2022 late-onset EPS</li><li>\u2022 presents as involuntary, repetitive movements,</li><li>\u2022 often of the mouth, lips, and tongue</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Acute dystonia is the earliest side effect of antipsychotics can be seen within minutes of receiving an injectable antipsychotic (also with oral antipsychotic). It is characterized by sudden contraction of a muscle group and can lead to symptoms like torticollis (twisting of the neck), oculogyric crisis (deviation of eyeballs), opisthotonos (extreme arching of the back), trismus (contraction of jaw muscles) or other dystonic reactions.</li><li>\u27a4 earliest side effect</li><li>\u27a4 antipsychotics</li><li>\u27a4 minutes of receiving an injectable antipsychotic</li><li>\u27a4 sudden contraction</li><li>\u27a4 torticollis</li><li>\u27a4 oculogyric crisis</li><li>\u27a4 opisthotonos</li><li>\u27a4 Ref: The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 110-111.</li><li>\u27a4 Ref:</li><li>\u27a4 The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 110-111.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "17f028b3",
      "audio": ""
    },
    {
      "text": "A 32-year-old patient with a diagnosis of schizophrenia, who is currently being treated with trifluoperazine, has developed a recent onset of rigidity and tremors. Based on the clinical presentation, which of the following is the most appropriate intervention to manage these symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Lorazepam",
          "correct": false
        },
        {
          "label": "B",
          "text": "Propranolol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Trihexyphenidyl",
          "correct": true
        },
        {
          "label": "D",
          "text": "Tetrabenazine",
          "correct": false
        }
      ],
      "correct_answer": "C. Trihexyphenidyl",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Trihexyphenidyl</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Lorazepam is not the primary treatment for drug-induced parkinsonism . It can be useful in catatonia or acute dystonia but is not the optimal choice for this patient\u2019s presentation.</li><li>\u2022 Option A: Lorazepam</li><li>\u2022 not the primary treatment for drug-induced parkinsonism</li><li>\u2022 Option B: Propranolol is a beta-blocker primarily used for akathisia and is not used to treat drug-induced parkinsonism.</li><li>\u2022 Option B: Propranolol</li><li>\u2022 beta-blocker primarily used for akathisia</li><li>\u2022 Option D: Tetrabenazine is used to treat hyperkinetic movement disorders such as Huntington\u2019s disease and tardive dyskinesia and is not indicated for drug-induced parkinsonism. In fact, it could potentially worsen the patient's symptoms.</li><li>\u2022 Option D: Tetrabenazine</li><li>\u2022 treat hyperkinetic movement disorders such as Huntington\u2019s disease and tardive dyskinesia</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Drug induced parkinsonism is characterized by the triad of rigidity, bradykinesia and resting tremors (3-6 Hz). The treatment options include use of anticholinergics (e.g., trihexyphenidyl, diphenhydramine) or change of antipsychotics to \u200b\u200bsecond generation or low potency first generation antipsychotics. The dose reduction can also be tried. Often, use of prophylactic anticholinergics prevents the development of drug induced parkinsonism.</li><li>\u27a4 Drug induced parkinsonism</li><li>\u27a4 triad of rigidity, bradykinesia and resting tremors</li><li>\u27a4 anticholinergics</li><li>\u27a4 change of antipsychotics to \u200b\u200bsecond generation or low potency first generation antipsychotics.</li><li>\u27a4 Ref: The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 110-111.</li><li>\u27a4 Ref:</li><li>\u27a4 The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 110-111.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e4ab96b4",
      "audio": ""
    },
    {
      "text": "Which of the following agents is associated with maximum metabolic side effects and least extrapyramidal side effects?",
      "options": [
        {
          "label": "A",
          "text": "Olanzapine",
          "correct": true
        },
        {
          "label": "B",
          "text": "Chlorpromazine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Quetiapine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Amisulpride",
          "correct": false
        }
      ],
      "correct_answer": "A. Olanzapine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Olanzapine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: Chlorpromazine is a first-generation (typical) antipsychotic and is associated with a higher risk of extrapyramidal side effects compared to olanzapine.</li><li>\u2022 Option B:</li><li>\u2022 Chlorpromazine</li><li>\u2022 first-generation</li><li>\u2022 antipsychotic</li><li>\u2022 higher risk of extrapyramidal side effects</li><li>\u2022 Option C: Quetiapine has metabolic side effects , though typically not as pronounced as olanzapine. Its risk for EPS is also relatively low.</li><li>\u2022 Option C:</li><li>\u2022 Quetiapine</li><li>\u2022 metabolic side effects</li><li>\u2022 Option D: Amisulpride is an atypical antipsychotic with a more pronounced risk for extrapyramidal side effects compared to olanzapine and quetiapine. Its metabolic side effect profile is less than that of olanzapine.</li><li>\u2022 Option D:</li><li>\u2022 Amisulpride</li><li>\u2022 atypical antipsychotic</li><li>\u2022 more pronounced risk for extrapyramidal side effects</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Metabolic side effects are seen more with atypical than typical antipsychotics , due to their H1 antagonism and 5HT2C antagonism. It is seen most with clozapine followed by olanzapine. Extrapyramidal side effects, on the other hand, are seen more with typical than atypical antipsychotics. Clozapine is least associated with EPS .</li><li>\u2022 Metabolic side effects</li><li>\u2022 atypical than typical antipsychotics</li><li>\u2022 H1 antagonism and 5HT2C antagonism.</li><li>\u2022 clozapine followed by olanzapine.</li><li>\u2022 Clozapine is least associated with EPS</li><li>\u2022 Ref: The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 109, 123.</li><li>\u2022 Ref:</li><li>\u2022 The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 109, 123.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d86b3695",
      "audio": ""
    },
    {
      "text": "A 29-year-old male with a confirmed diagnosis of schizophrenia has been undergoing treatment with haloperidol. While there is a noticeable improvement in the positive symptoms of his condition, he has concurrently developed troubling side effects, including akathisia and dystonia. Given this clinical scenario, which of the following pharmacological agents would be most beneficial to address his current needs?",
      "options": [
        {
          "label": "A",
          "text": "Penfluriodl",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lurasidone",
          "correct": true
        },
        {
          "label": "C",
          "text": "Fluphenazine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lithium",
          "correct": false
        }
      ],
      "correct_answer": "B. Lurasidone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Lurasidone</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Penfluridol and C. Fluphenazine are both typical antipsychotics, like haloperidol , and are likely to carry a similar risk of EPS . Therefore, they would not be the best choices for this patient given the side effects he is experiencing.</li><li>\u2022 Option A. Penfluridol</li><li>\u2022 C. Fluphenazine</li><li>\u2022 both typical antipsychotics,</li><li>\u2022 haloperidol</li><li>\u2022 carry a similar risk of EPS</li><li>\u2022 Option D. Lithium is primarily used to treat bipolar disorder and is not typically used as monotherapy for schizophrenia , especially when the concern is managing EPS.</li><li>\u2022 Option D. Lithium</li><li>\u2022 used to treat bipolar disorder and is not typically used as monotherapy for schizophrenia</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Lurasidone presents a lower risk of EPSE while effectively managing the positive symptoms of schizophrenia.</li><li>\u27a4 Lurasidone</li><li>\u27a4 lower risk of EPSE</li><li>\u27a4 positive symptoms of schizophrenia.</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 614-615.</li><li>\u27a4 Ref:</li><li>\u27a4 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 614-615.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9180b293",
      "audio": ""
    },
    {
      "text": "A 28-year-old woman presents to the emergency department with her mother, who expresses concern about her daughter's inability to remain stationary over the past week, noting excessive leg movement. The patient was recently started on risperidone for newly diagnosed schizophrenia. Since then, she has been unable to sit still and constantly feels the need to move. She describes a subjective feeling of inner restlessness, compelling her to walk around and shift her weight from one foot to the other when standing. She has no history of substance abuse, and there are no signs of intoxication. Her vital signs are within normal limits, and neurological examination does not reveal any abnormal movements like tremors or rigidity. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Neuroleptic malignant syndrome.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Restless leg syndrome.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Acute akathisia.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Tardive dyskinesia.",
          "correct": false
        }
      ],
      "correct_answer": "C. Acute akathisia.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Acute akathisia.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Neuroleptic malignant syndrome is a life-threatening reaction to antipsychotic drugs characterized by fever, autonomic dysfunction, altered mental status, and generalized muscle rigidity.</li><li>\u2022 Option A:</li><li>\u2022 Neuroleptic malignant syndrome</li><li>\u2022 life-threatening reaction to antipsychotic drugs</li><li>\u2022 Option B: Restless leg syndrome is an urge to move the legs, usually accompanied by uncomfortable sensations , which typically worsen at night and are relieved by movement.</li><li>\u2022 Option B:</li><li>\u2022 Restless leg syndrome</li><li>\u2022 urge to move the legs, usually accompanied by uncomfortable sensations</li><li>\u2022 Option D: Tardive dyskinesia is a late-appearing side effect of antipsychotic medications characterized by repetitive, involuntary, and purposeless movements, often of the mouth, lips, and tongue (like lip-smacking or chewing).</li><li>\u2022 Option D:</li><li>\u2022 Tardive dyskinesia</li><li>\u2022 late-appearing side effect of antipsychotic medications</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Acute akathisia is the commonest side effect of antipsychotic medications. It is characterized by an inner sense of restlessness along with objective , observable movements such as fidgeting of legs, pacing around , inability to sit or stand in one place for a long time. Drug of choice is \u03b2-blockers such as propranolol. Other treatment options include anticholinergics and benzodiazepines .</li><li>\u27a4 commonest side effect</li><li>\u27a4 inner sense of restlessness</li><li>\u27a4 objective</li><li>\u27a4 observable movements</li><li>\u27a4 fidgeting</li><li>\u27a4 pacing around</li><li>\u27a4 inability to sit</li><li>\u27a4 stand</li><li>\u27a4 Drug of choice</li><li>\u27a4 \u03b2-blockers</li><li>\u27a4 anticholinergics</li><li>\u27a4 benzodiazepines</li><li>\u27a4 Ref: The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 110-111.</li><li>\u27a4 Ref:</li><li>\u27a4 The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 110-111.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d36ce393",
      "audio": ""
    },
    {
      "text": "A 29-year-old man with schizophrenia presents to the outpatient psychiatric clinic with concerns about recently developed breast enlargement and tenderness. He states that he has been adhering to his medication regimen, which includes risperidone. His psychiatrist explains that some antipsychotic medications can lead to elevated prolactin levels, which can cause such symptoms. Curious, the patient asks about how the medication leads to this change. Which of the following best explains the pathophysiology behind antipsychotic-induced hyperprolactinemia?",
      "options": [
        {
          "label": "A",
          "text": "Direct stimulation of the anterior pituitary gland by the antipsychotic.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Induction of hypothalamic hormones stimulating prolactin production.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Decrease in serotonin-mediated prolactin release.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Blockade of dopamine D 2 receptors in tuberoinfundibular tract leading to increased prolactin release.",
          "correct": true
        }
      ],
      "correct_answer": "D. Blockade of dopamine D 2 receptors in tuberoinfundibular tract leading to increased prolactin release.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Blockade of dopamine D2 receptors in tuberoinfundibular tract leading to increased prolactin release.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Antipsychotics do not directly stimulate the anterior pituitary gland to release prolactin.</li><li>\u2022 Option A:</li><li>\u2022 Antipsychotics</li><li>\u2022 do not directly stimulate the anterior pituitary gland</li><li>\u2022 Option B: Antipsychotics do not typically induce hypothalamic hormones to stimulate prolactin production.</li><li>\u2022 Option B:</li><li>\u2022 Antipsychotics do not typically induce hypothalamic hormones</li><li>\u2022 Option C: Serotonin , if anything, increases prolactin release , but its role in antipsychotic-induced hyperprolactinemia is not the primary mechanism.</li><li>\u2022 Option C:</li><li>\u2022 Serotonin</li><li>\u2022 increases prolactin release</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hyperprolactinemia can occur secondary to antipsychotic use due to blockage of D2 receptors in the tuberoinfundibular tract . Clinical features include galactorrhea, menstrual disturbances in females and gynecomastia, impotence in males. First choice for management of antipsychotic induced hyperprolactinemia is Aripiprazole. Second choices include dopamine agonists such as cabergoline, bromocriptine, amantadine etc, and metformin.</li><li>\u27a4 tuberoinfundibular tract</li><li>\u27a4 First choice for management of antipsychotic induced hyperprolactinemia is Aripiprazole.</li><li>\u27a4 Ref: The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 168-169.</li><li>\u27a4 Ref:</li><li>\u27a4 The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 168-169.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "07dfad5f",
      "audio": ""
    },
    {
      "text": "A 56-year-old male with a history of schizophrenia is started on chlorpromazine, a typical antipsychotic medication. The patient subsequently reports experiencing sedation, dry mouth, episodes of hypotension, tremors and rigidity. These side effects are related to the drug's interaction with specific receptors. Which combination of receptors is implicated in the side effects experienced by this patient? D2 and 5HT2 receptors GABA and alpha-adrenergic receptors Muscarinic M1 and alpha-adrenergic receptors H1 receptors",
      "options": [
        {
          "label": "A",
          "text": "1, 3 and 4 are correct",
          "correct": true
        },
        {
          "label": "B",
          "text": "Only 2 is correct",
          "correct": false
        },
        {
          "label": "C",
          "text": "1 and 2 are correct",
          "correct": false
        },
        {
          "label": "D",
          "text": "All are correct",
          "correct": false
        }
      ],
      "correct_answer": "A. 1, 3 and 4 are correct",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) 1, 3 and 4 are correct</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Chlorpromazine (a low-potency typical antipsychotic) has the following receptor interactions related to the side effects mentioned:</li><li>\u27a4 D2 receptor antagonism: Causes extrapyramidal symptoms (tremors, rigidity) Muscarinic (M1) receptor antagonism: Causes anticholinergic effects (dry mouth) Alpha-adrenergic receptor antagonism: Causes orthostatic hypotension H1 receptor antagonism: Causes sedation</li><li>\u27a4 D2 receptor antagonism: Causes extrapyramidal symptoms (tremors, rigidity)</li><li>\u27a4 Muscarinic (M1) receptor antagonism: Causes anticholinergic effects (dry mouth)</li><li>\u27a4 Alpha-adrenergic receptor antagonism: Causes orthostatic hypotension</li><li>\u27a4 H1 receptor antagonism: Causes sedation</li><li>\u27a4 Chlorpromazine has minimal effect on GABA receptors</li><li>\u27a4 Ref : Stahl\u2019s Essential Psychopharmacology, Neuroscientific basis and practical applications, 5th edition, Page No 201-202.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b411400a",
      "audio": ""
    },
    {
      "text": "A 28-year-old female presents to the psychiatry clinic for a follow-up. She has a long-standing diagnosis of treatment-resistant schizophrenia and has been under various antipsychotic medications with suboptimal response and significant side effects. Due to the persistence and severity of her positive and negative symptoms, the consulting psychiatrist is considering clozapine. The resident doctor, wanting to ensure she understands the nuances of clozapine treatment, discusses with her attending physician about the drug's profile. The consultant asks the resident: \"Which of the following statements regarding clozapine is not true?\"",
      "options": [
        {
          "label": "A",
          "text": "It causes the highest weight gain amongst all antipsychotics.",
          "correct": false
        },
        {
          "label": "B",
          "text": "WBC count of less than 3500/dL at the time of starting clozapine is a contraindication.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Blood levels of clozapine should be maintained <350 ng/mL to avoid agranulocytosis.",
          "correct": true
        },
        {
          "label": "D",
          "text": "It should not be used along with carbamazepine.",
          "correct": false
        }
      ],
      "correct_answer": "C. Blood levels of clozapine should be maintained <350 ng/mL to avoid agranulocytosis.",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/screenshot-2024-03-12-144608.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/12/screenshot-2024-03-12-144651.jpg"
      ],
      "explanation": "<p><strong>Ans. C) Blood levels of clozapine should be maintained <350 ng/mL to avoid agranulocytosis.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: True. Clozapine is known for causing significant weight gain , and among all antipsychotics , it is indeed most associated with this side effect.</li><li>\u2022 Option A: True.</li><li>\u2022 Clozapine</li><li>\u2022 causing significant weight gain</li><li>\u2022 antipsychotics</li><li>\u2022 Option B: True. Clozapine carries a risk of agranulocytosis , a potentially life-threatening decrease in the number of white blood cells . As such, monitoring of white blood cell (WBC) counts is mandatory for patients on clozapine. A baseline WBC count below 3500/dL is considered a contraindication to initiate the drug.</li><li>\u2022 Option B: True.</li><li>\u2022 Clozapine carries a risk of agranulocytosis</li><li>\u2022 potentially life-threatening decrease in the number of white blood cells</li><li>\u2022 Option D: True. Carbamazepine , an anticonvulsant, can cause a drop in WBC count . Given clozapine's risk of agranulocytosis, combining it with carbamazepine can further increase this risk.</li><li>\u2022 Option D: True.</li><li>\u2022 Carbamazepine</li><li>\u2022 anticonvulsant,</li><li>\u2022 drop in WBC count</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Clozapine is the drug of choice in treatment-resistant schizophrenia. Contraindications for clozapine use include WBC< 3500/dl, history of agranulocytosis on clozapine, or use of other bone marrow suppressants like carbamazepine</li><li>\u27a4 Clozapine is the drug of choice in treatment-resistant schizophrenia.</li><li>\u27a4 Ref: The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 222.</li><li>\u27a4 Ref:</li><li>\u27a4 The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 222.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a538bb43",
      "audio": ""
    },
    {
      "text": "A 62-year-old woman presents to the psychiatry clinic referred from dermatologist with severe distress over a persistent belief that she is infested with bugs. She reports feeling them crawl on and under her skin, especially at night, and has multiple self-inflicted excoriated lesions on her arms and legs from trying to \"remove the bugs.\" She has seen multiple physicians, and all diagnostic evaluations, including skin biopsies, have returned negative for parasitic infestations. Her family is concerned about her increasing isolation, noting she has thrown out furniture and avoids family gatherings, fearing she might spread the \"infestation.\" Despite evidence to the contrary, she firmly believes in the presence of the parasites and has even brought in small lint balls from her bed, claiming they are the bugs. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "De Clerambault's syndrome.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Schizophrenia.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cocaine bugs.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Delusional parasitosis.",
          "correct": true
        }
      ],
      "correct_answer": "D. Delusional parasitosis.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Delusional parasitosis.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Delusional parasitosis, also known as Ekbom syndrome, is a psychiatric disorder in which patients have a delusion that they are infested by parasites or small creatures. They often present to dermatologists with \"evidence of parasites\" collected in a container (known as matchbox sign- Patients present with items they believe are parasites or worms. The items are usually stored in a small container, like a matchbox). Treatment includes antipsychotic medications, like pimozide or risperidone. While Willis Ekbom disease is another name for Restless less syndrome.</li><li>\u27a4 Ref : New Oxford Textbook of Psychiatry, 3rd edition, Page No 623-624.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a8e263ae",
      "audio": ""
    },
    {
      "text": "A 30-year-old male presents to the psychiatric clinic accompanied by his 60-year-old father. The father reports increasing concern regarding his son's behavior over the past few months. He explains that his son has become increasingly suspicious of their neighbors, often voicing concerns that they are plotting against him. He spends hours peeking through curtains and has even set up cameras. What deeply worries the father, however, is that over the past six weeks, the patient's 25-year-old sister has begun exhibiting similar behavior. She now avoids the neighbors, claiming they are plotting against her as well. Both siblings previously had good relationships with these neighbors and there's no concrete evidence to support their beliefs. Which of the following terms best describes this scenario?",
      "options": [
        {
          "label": "A",
          "text": "Folie \u00e0 deux",
          "correct": true
        },
        {
          "label": "B",
          "text": "Folie \u00e0 trois",
          "correct": false
        },
        {
          "label": "C",
          "text": "Bizarreness",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cotard\u2019s syndrome",
          "correct": false
        }
      ],
      "correct_answer": "A. Folie \u00e0 deux",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Folie \u00e0 deux.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: Folie \u00e0 trois: Similar to Folie \u00e0 deux , but the delusional belief is shared between three close individuals.</li><li>\u2022 Option B: Folie \u00e0 trois:</li><li>\u2022 Similar to Folie \u00e0 deux</li><li>\u2022 Option C: Bizarreness: Bizarre delusions are scientifically impossible and culturally implausible. While the belief may be bizarre, this term alone doesn't account for the shared nature of the delusion between two people.</li><li>\u2022 Option C: Bizarreness:</li><li>\u2022 scientifically impossible and culturally implausible.</li><li>\u2022 Option D: Cotard\u2019s syndrome: A rare mental illness in which the affected person holds the delusional belief that they are dead, nonexistent, or have lost their blood or internal organs.</li><li>\u2022 Option D: Cotard\u2019s syndrome:</li><li>\u2022 rare mental illness in which the affected person holds the delusional belief</li><li>\u2022 dead, nonexistent,</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Shared psychotic disorder is characterized by spread of delusions from one person to another . The individual who has the delusion (the primary case) is typically the influential member of a close relationship with a more suggestible person (the secondary case) who also develops the delusion. When two people are involved, the term \u201cfolie \u00e0 deux\u201d is used. Occasionally more than two individuals are involved (known as folie \u00e0 trois, folie \u00e0 quatre etc). Treatment includes separating the individuals as part of the treatment strategy , which often leads to resolution of the shared delusional beliefs in the secondary individual. Treatment with antipsychotic medications can be beneficial for the primary affected individual.</li><li>\u2022 spread of delusions from one person to another</li><li>\u2022 delusion</li><li>\u2022 \u201cfolie \u00e0 deux\u201d</li><li>\u2022 folie \u00e0 trois, folie \u00e0 quatre</li><li>\u2022 Treatment includes</li><li>\u2022 separating the individuals as part of the treatment strategy</li><li>\u2022 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 347.</li><li>\u2022 Ref:</li><li>\u2022 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 347.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4f9ac2d8",
      "audio": ""
    },
    {
      "text": "A 19-year-old college student contacts his parents, expressing intense fear that the Mafia is targeting him. He shares that for the past six weeks, he's only consumed canned beans, stating, \"they have eyes everywhere, and I can't risk it.\" He's certain that there are cameras placed by the Mafia in his hostel room to monitor him. Occasionally, he hears discussions about him, though no one is nearby. His roommate states that for the past 2 months the patient has been increasingly withdrawn and suspicious. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Delusional disorder",
          "correct": false
        },
        {
          "label": "B",
          "text": "Schizoaffective disorder",
          "correct": false
        },
        {
          "label": "C",
          "text": "Schizophreniform disorder",
          "correct": true
        },
        {
          "label": "D",
          "text": "Schizophrenia",
          "correct": false
        }
      ],
      "correct_answer": "C. Schizophreniform disorder",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Schizophreniform disorder</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "250dacd8",
      "audio": ""
    },
    {
      "text": "A 35-year-old individual presents to the outpatient psychiatric clinic with a history of peculiar verbal responses. When asked introductory questions, the patient tends to immediately repeat the exact phrases spoken to them. The healthcare provider observes this pattern consistently throughout the interaction. Which of the following psychiatric phenomena is the patient most likely displaying?",
      "options": [
        {
          "label": "A",
          "text": "Echolalia",
          "correct": true
        },
        {
          "label": "B",
          "text": "Echopraxia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Perseveration",
          "correct": false
        },
        {
          "label": "D",
          "text": "Posturing",
          "correct": false
        }
      ],
      "correct_answer": "A. Echolalia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Echolalia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B: Echopraxia is the involuntary imitation of another person's movements and is not the correct answer since the patient is repeating words, not actions.</li><li>\u2022 Option B: Echopraxia</li><li>\u2022 involuntary imitation of another person's movements</li><li>\u2022 Option C: Perseveration is the repetition of the same response beyond the point of relevance .</li><li>\u2022 Option C: Perseveration</li><li>\u2022 repetition of the same response beyond the point of relevance</li><li>\u2022 Option D: Posturing refers to the adoption of fixed, abnormal body positions for an extended period and is not relevant to the patient\u2019s presenting symptom of repeating spoken words.</li><li>\u2022 Option D: Posturing</li><li>\u2022 adoption of fixed, abnormal body positions for an extended period</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Echolalia is the repetition of speech often seen in catatonia .</li><li>\u27a4 Echolalia</li><li>\u27a4 repetition of speech often seen in catatonia</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 11th edition, Page No 345.</li><li>\u27a4 Ref:</li><li>\u27a4 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 11th edition, Page No 345.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5a4dc9b2",
      "audio": ""
    }
  ]
}